-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 OakfQT2QxgAzbSQ/Nobs3ZyMQfpGuRPD7iOEa1C3eh6/KiaDssLWwaZQgqWf1jl3
 6tadgLyvP8SlvszYm6aylg==

<SEC-DOCUMENT>0001325310-09-000038.txt : 20090721
<SEC-HEADER>0001325310-09-000038.hdr.sgml : 20090721
<ACCEPTANCE-DATETIME>20090721172559
ACCESSION NUMBER:		0001325310-09-000038
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		8
CONFORMED PERIOD OF REPORT:	20090717
FILED AS OF DATE:		20090721
DATE AS OF CHANGE:		20090721

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALDA Pharmaceuticals Corp.
		CENTRAL INDEX KEY:			0001355736
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51848
		FILM NUMBER:		09955717

	BUSINESS ADDRESS:	
		STREET 1:		635 COLUMBIA STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E1T9
		BUSINESS PHONE:		6045218300

	MAIL ADDRESS:	
		STREET 1:		635 COLUMBIA STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E1T9
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6kjuly2009news.htm
<DESCRIPTION>FORM 6K
<TEXT>
<HTML>
<head><title>OMB APPROVAL</title> </head> <body style="LINE-HEIGHT:12pt; FONT-FAMILY:Times New Roman; COLOR:#000000; FONT-SIZE:10pt">
<div style=WIDTH:960px> <p style=MARGIN:0px><br><br><br></p> <table style=FONT-SIZE:10pt cellspacing=0>
<tr height=0 style=FONT-SIZE:0px> <td width=727> <td width=204 /> <tr> <td width=727 style="BORDER-RIGHT:#000000 1px solid" valign=top>
<p>&nbsp;</p></td> <td width=204 style="BORDER-BOTTOM:#000000 1px solid; BORDER-TOP:#000000 1px solid; BORDER-RIGHT:#000000 1px solid" valign=top>
<p style="LINE-HEIGHT:10pt; MARGIN-TOP:1px; FONT-FAMILY:Arial; MARGIN-BOTTOM:1px; FONT-SIZE:8pt" align=center>OMB APPROVAL</p></td></tr>
<tr> <td width=727 style="BORDER-RIGHT:#000000 1px solid" valign=top> <p>&nbsp;</p></td> <td width=204 style="BORDER-BOTTOM:#000000 1px solid; BORDER-RIGHT:#000000 1px solid" valign=top>
<p style="LINE-HEIGHT:10pt; MARGIN-TOP:1px; FONT-FAMILY:Arial; MARGIN-BOTTOM:0px; FONT-SIZE:8pt" align=center>OMB Number: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3235-0116
<br>Expires: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;March 31, 2011
<br>Estimated average burden &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<font style=BACKGROUND-COLOR:#ffffff>.<br></font>hours per response &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.70</p></td></tr></table>
<p style=MARGIN:0px><br></p> <p style="LINE-HEIGHT:18pt; MARGIN:0px; FONT-SIZE:16pt" align=center><b>UNITED STATES</b></p>
<p style="LINE-HEIGHT:18pt; MARGIN:0px; FONT-SIZE:16pt" align=center><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
<p style="LINE-HEIGHT:18pt; MARGIN:0px; FONT-SIZE:16pt" align=center><b>Washington, D.C. 20549</b></p>
<p style=MARGIN:0px align=center><br></p> <p style="LINE-HEIGHT:16pt; MARGIN:0px; FONT-SIZE:14pt" align=center>
<b>Form 6-K</b></p> <p style=MARGIN:0px align=center><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=center>
<b>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</b></p>
<p style=MARGIN:0px><br></p> <p style=MARGIN:0px>For the month of <b><u>JULY 2009</u></b></p> <p style=MARGIN:0px>
<br></p> <p style=MARGIN:0px>Commission File Number: <b><u>51848</u></b></p> <p style=MARGIN:0px><br></p>
<p style="LINE-HEIGHT:13pt; MARGIN:0px; FONT-SIZE:11pt" align=center><b><u>ALDA Pharmaceuticals Corp.</u></b></p>
<p style=MARGIN:0px align=center>(Translation of registrant&#146;s name into English)</p> <p style=MARGIN:0px align=center>
<br></p> <p style="LINE-HEIGHT:13pt; MARGIN:0px; FONT-SIZE:11pt" align=center><b><u>635 Columbia St. New Westminster, B.C., Canada, V3M 1A7</u></b></p>
<p style=MARGIN:0px align=center>(Address of principal executive office)</p> <p style=MARGIN:0px><br></p>
<p style=MARGIN:0px>Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</p>
<p style=MARGIN:0px>Form 20-F [X]<font style=FONT-FAMILY:Arial> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>&nbsp;Form 40-F
<font style=FONT-FAMILY:Arial>[ ]</font></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</p>
<p style=MARGIN:0px><br></p> <p style=MARGIN:0px><b>Note</b>: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</p>
<p style=MARGIN:0px><br></p> <p style=MARGIN:0px>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</p>
<p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=justify><b>Note: </b>Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant&#146;s &#147;home country&#148;), or under the rules of the home country exchange on which the registrant&#146;s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant&#146;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. &nbsp;</p>
<p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br><br></p> <p style="PAGE-BREAK-BEFORE:always; MARGIN:0px">Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. </p>
<p style=MARGIN:0px>Yes <font style=FONT-FAMILY:Arial>[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>No [X]</p>
<p style=MARGIN:0px><br></p> <p style=MARGIN:0px>If &#147;Yes&#148; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):</p>
<p style=MARGIN:0px>82-_______________.</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p>
<p style="LINE-HEIGHT:13pt; MARGIN:0px; FONT-SIZE:11pt">Documents Included as Part of this Report</p>
<p style=MARGIN:0px><br></p> <table style=FONT-SIZE:10pt cellspacing=0> <tr height=0 style=FONT-SIZE:0px>
<td width=80> <td width=539 /> <tr> <td width=80 valign=top> <p style="LINE-HEIGHT:13pt; MARGIN:0px; FONT-SIZE:11pt">
<b><u>Exhibit No.</u></b></p></td> <td width=539 valign=top> <p style="LINE-HEIGHT:13pt; MARGIN:0px; FONT-SIZE:11pt">
<b><u>Document</u></b></p></td></tr> <tr> <td width=80> <p style="LINE-HEIGHT:13pt; MARGIN:0px; FONT-SIZE:11pt" align=center>1.</p></td>
<td width=539> <p style="LINE-HEIGHT:13pt; MARGIN:0px; FONT-SIZE:11pt"><a href=nr20090714uspatentcont.htm>News Release dated July 14, 2009 &#150; US Patent Continuation</a></p></td></tr>
<tr> <td width=80> <p style="LINE-HEIGHT:13pt; MARGIN:0px; FONT-SIZE:11pt" align=center>2.</p></td> <td width=539>
<p style="LINE-HEIGHT:13pt; MARGIN:0px; FONT-SIZE:11pt"><a href=nr20090715vanoc.htm>News Release dated July 15, 2009 - VANOC</a></p></td></tr>
<tr> <td width=80> <p style="LINE-HEIGHT:13pt; MARGIN:0px; FONT-SIZE:11pt" align=center>3.</p></td> <td width=539>
<p style="LINE-HEIGHT:13pt; MARGIN:0px; FONT-SIZE:11pt"><a href=nr20090717ppincrease.htm>News Release dated July 17, 2009 &#150; Private Placement Increase</a></p></td></tr></table>
<p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=center><b>SIGNATURES</b></p> <p style=MARGIN:0px>
<br></p> <p style="LINE-HEIGHT:13pt; MARGIN:0px; FONT-SIZE:11pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Form 6-K to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
<p style=MARGIN:0px><br></p> <p style="LINE-HEIGHT:normal; TEXT-INDENT:360px; MARGIN:0px; FONT-SIZE:11pt">
<b>ALDA Pharmaceuticals Corp.</b><font style=FONT-SIZE:10pt> </font></p> <p style=MARGIN:0px>Date:<u> July 21, 2009 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
<p style="MARGIN-TOP:0px; TEXT-INDENT:336px; MARGIN-BOTTOM:-16px">By: </p> <p style="LINE-HEIGHT:normal; TEXT-INDENT:384px; MARGIN:0px">&#147;
<font style="COLOR:#00007f; FONT-SIZE:12pt"><b><i>Terrance G. Owen</i></b></font>&#148;</p> <p style=MARGIN:0px>
<br></p> <p style="MARGIN-TOP:0px; TEXT-INDENT:336px; MARGIN-BOTTOM:-16px">Name: </p> <p style="TEXT-INDENT:384px; MARGIN:0px">Terrance G. Owen, Ph.D., M.B.A.</p>
<p style="LINE-HEIGHT:10.4pt; MARGIN-TOP:0px; PADDING-LEFT:336px; MARGIN-BOTTOM:-13px">Title: &nbsp;</p>
<p style="LINE-HEIGHT:8.4pt; TEXT-INDENT:48px; MARGIN:0px; PADDING-LEFT:336px">President & CEO</p> <p style=MARGIN:0px>
<br></p> <p style=MARGIN:0px><br><br></p></div></body>
<!-- EDGAR Validation Code: 37EDB235 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2
<SEQUENCE>2
<FILENAME>nr20090715vanoc.htm
<DESCRIPTION>NEWS RELEASE DATED JULY 15, 2009 - VANCO
<TEXT>
<HTML>
<head><title>ALDA News Release</title> </head> <body style="LINE-HEIGHT:12pt; FONT-FAMILY:Times New Roman; COLOR:#000000; FONT-SIZE:10pt">
<table style=FONT-SIZE:10pt cellspacing=0> <tr height=0 style=FONT-SIZE:0px> <td width=487 /> <td width=487 /></tr>
<tr> <td width=487 valign=top> <p style=MARGIN:0px><img width=217 alt=[nr20090715vanoc001.jpg] height=64 src=nr20090715vanoc001.jpg align=middle></p></td>
<td width=487 valign=top> <p style=MARGIN:0px align=right><img width=246 alt=[nr20090715vanoc002.jpg] height=62 src=nr20090715vanoc002.jpg align=middle></p></td></tr></table>
<div style=WIDTH:960px> <p style=MARGIN:0px align=center><br></p> <p style="LINE-HEIGHT:18.6pt; MARGIN-TOP:0px; MARGIN-BOTTOM:25px; FONT-SIZE:18pt" align=center>
<b>ALDA PHARMACEUTICALS CORP.</b></p> <p style="LINE-HEIGHT:12.6pt; MARGIN:0px; FONT-SIZE:12pt" align=center>
<b>635 Columbia Street<br>New Westminster, British Columbia V3M 1A7</b></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=center>
<b>Tel: (604) 521-8300 Fax: (604) 521-8322</b></p> <p style=MARGIN:0px align=center><br></p> <p style="LINE-HEIGHT:18pt; MARGIN:0px; FONT-SIZE:16pt" align=center>
<b>NEWS RELEASE</b></p> <p style=MARGIN:0px align=center><br></p> <p style="LINE-HEIGHT:20pt; MARGIN:0px; FONT-SIZE:18pt" align=center>
<b>ALDA Pharmaceuticals Corp. named</b></p> <p style="LINE-HEIGHT:20pt; MARGIN:0px; FONT-SIZE:18pt" align=center>
<b>Official Supplier for the 2010 Winter Games</b></p> <p style=MARGIN:0px><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>
<b>July 15, 2009 - Vancouver, BC</b> &#151; <b>ALDA Pharmaceuticals Corp. (&#147;ALDA&#148;) (TSXV: APH)</b> is partnering with the Vancouver Organizing Committee for the 2010 Olympic and Paralympic Winter Games (VANOC) to keep venues healthy and sanitized as the exclusive Official Supplier of hand sanitizer and disinfectant cleaning products for the Games.</p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>The company, founded in 1996, publicly listed in 2003 and based in New Westminster, British Columbia, develops, manufactures and markets a family of proprietary infection control products based on its patented technology called T
<sup>3</sup>6<sup>&#174;</sup>. Under the agreement with VANOC, ALDA will make a financial investment in the Games and provide antiseptic hand sanitizer and handwipes, cleaning products and a hospital-grade spray disinfectant to the Organizing Committee. The hand sanitizer and handwipes will be available at competition and non-competition venues, including the Olympic/Paralympic Villages, polyclinic centres and food preparation areas.</p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>In return, ALDA will have exclusive rights as an Official Supplier in the Hand Sanitizer and Disinfectant Cleaning Products product category for the 2010 Winter Games and rights to associate with the Canadian Olympic Team competing at the Vancouver 2010 Olympic Winter Games and the London 2012 Olympic Games.</p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>&#147;Our company is excited to play a role in helping ensure the 2010 Winter Games are among the healthiest ever held for athletes, spectators, volunteers and workers,&#148; said Terrance G. Owen, president and CEO of ALDA Pharmaceuticals Corp. &#147;The Games are a perfect event to put our new consumer products, such as our antiseptic hand sanitizer, literally in the hands of potentially tens of thousands of people from around the world and help ensure the only things they take away from the Games are fun and memorable experiences.&#148;</p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>&#147;We&#146;re pleased to welcome this growing British Columbian company to the Vancouver 2010 team,&#148; said John Furlong, VANOC Chief Executive Officer. &#147;We look forward to working with ALDA Pharmaceuticals and using their innovative line of sanitizing products to help us deliver great </p>
<p style=MARGIN:0px align=justify>&nbsp;</p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>Games when we welcome the world in 2010.&#148;</p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>British Columbia Premier Gordon Campbell added, &#147;Strong partnerships are critical as we prepare to welcome the world in 2010. When thousands of athletes, teams, journalists and visitors come here to experience our province and the Vancouver 2010 Olympic and Paralympic Winter Games, this partnership will help to ensure their health and safety.&#148;</p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>Compared to typical alcohol-based hand sanitizers, ALDA&#146;s antiseptic hand sanitizer has two active ingredients that provide faster action against a broader range of infectious organisms, including Norwalk-like viruses and that offer a long-lasting residual effect.</p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>The company&#146;s hospital-grade disinfectant spray has been tested on more than 25 clinically important bacteria, viruses and fungi, and is approved for hospital use by Health Canada and the Canadian Food Inspection Agency (CFIA) for restaurants and the food processing industry. The spray kills infectious organisms such as polio, HIV and tuberculosis.</p>
<p style=MARGIN:0px><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>&#147;VANOC takes our responsibility to ensure the Games are a healthy and safe place for all involved very seriously,&#148; said VANOC&#146;s chief medical officer, Dr. Jack Taunton. &#147;ALDA is a great partner for the Games &#151; it has undergone rigorous independent testing of its products and has been recognized by both Health Canada and the CFIA.&#148;</p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>
<b>About ALDA Pharmaceuticals Corp.</b></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>ALDA is focused on the development of infection-control therapeutics derived from its patented T
<sup>3</sup>6<sup>&#174;</sup> technology. T<sup>3</sup>6<sup>&#174;</sup> has been proven effective against H1N1. The company trades on the TSX Venture Exchange under the symbol, &#147;APH&#148;, and is quoted on the OTCBB under the symbol, &#147;APCSF.&#148;</p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>
<b>About VANOC</b></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>VANOC is responsible for the planning, organizing, financing and staging of the XXI Olympic Winter Games and the X Paralympic Winter Games in 2010. The 2010 Olympic Winter Games will be staged in Vancouver and Whistler from February 12 to 28, 2010. Vancouver and Whistler will host the 2010 Paralympic Winter Games from March 12 to 21, 2010. Visit
<u>www.vancouver2010.com</u>.</p> <p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>VANOC's marketing program is focused on securing mutually rewarding partnerships with shared values to generate sufficient revenue to host successful Winter Games in 2010 and to leave a financial legacy for sport. VANOC&#146;s worldwide TOP Partners include Coca-Cola, Acer, Atos Origin, General Electric, McDonald&#146;s, Omega, Panasonic, Samsung and Visa. VANOC's National Partners are Bell Canada,&nbsp;Hudson&#146;s Bay Company, RBC Financial Group, General Motors of Canada, Petro-Canada and RONA.</p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>VANOC&#146;s Official Supporters include Air Canada, BC Hydro, Bombardier, the British Columbia Lottery Corporation, Canadian Pacific, Insurance Corporation of British Columbia (ICBC), Jet Set Sports, Ricoh Canada, Royal Canadian Mint and Teck Resources. VANOC&#146;s Official Suppliers are 3M, Acklands-Grainger, Aggreko, ALDA Pharmaceuticals Corp., Aquilini Investment Group, Birks, Britco, Canada Post, Canwest Publishing, COLD-FX, Deloitte, Dow Canada, EPCOR, Garrett Metal Detectors, General Mills, Hain Celestial Canada, Haworth Canada, Karl&#146;s Global Events Inc.,&nbsp;Jackson Triggs, La Presse, Millennium Development Corp., Molson, Nortel, Offsetters, Port Metro Vancouver, Purolator Courier Ltd., Saputo, Sleep Country Canada, Sun Microsystems of Canada, The Globe and Mail, Tickets.com, TransCanada, Vancouver Airport Authority, Weston Bakeries, Workopolis and Wrigley Canada.</p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>Terrance G. Owen, Ph.D., MBA</p>
<p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; FONT-SIZE:12pt">President & CEO <br>ALDA Pharmaceuticals Corp.</p>
<p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; COLOR:#0000ff; FONT-SIZE:12pt"><i><u>www.aldacor
<a name=_Hlt115846424 />p.com</u></i></p> <p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; FONT-SIZE:12pt" align=justify>
<u>VANOC Media Contact:</u></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>Jason Macnaughton</p>
<p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>VANOC Communications</p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>604.403.2734</p>
<p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; COLOR:#0000ff; FONT-SIZE:12pt" align=justify>
<i><u>jason_macnaughton@vancouver2010.com</u></i></p> <p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; FONT-SIZE:12pt" align=justify>
<u>ALDA Investor Relations Contact</u></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; FONT-SIZE:12pt" align=justify>Scott Young</p>
<p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>604-288-7222</p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; COLOR:#0000ff; FONT-SIZE:12pt" align=justify>
<i><u>syoung@freeformcom.com</u></i><font style=COLOR:#000000> </font></p> <p style="LINE-HEIGHT:12.6pt; MARGIN:0px" align=justify>
<br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify><i>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.</i></p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>
<i>Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves ALDA&#146;s expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. ALDA generally uses words such as &#147;outlook,&#148; &#147;will,&#148; &#147;could,&#148; &#147;would,&#148; &#147;might,&#148; &#147;remains,&#148; &#147;to be,&#148; &#147;plans,&#148; &#147;believes,&#148; &#147;may,&#148; &#147;expects,&#148; &#147;intends,&#148; &#147;anticipates,&#148; &#147;estimate,&#148; &#147;future,&#148; &#147;plan,&#148; &#147;positioned,&#148; &#147;potential,&#148; &#147;project,&#148; &#147;remain,&#148; &#147;scheduled,&#148; &#147;set to,&#148; &#147;subject to,&#148; &#147;upcoming,&#148; and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon information available to ALDA as of the date of this release, and ALDA assume
s no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of ALDA and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.</i> </p>
<p style=MARGIN:0px align=justify><br></p> <p style=MARGIN:0px align=justify><br></p></div> <table style=FONT-SIZE:10pt cellspacing=0>
<tr height=0 style=FONT-SIZE:0px> <td width=487 /> <td width=487 /></tr> <tr> <td width=487 valign=top>
<p style=MARGIN:0px><img width=217 alt=[nr20090715vanoc003.jpg] height=64 src=nr20090715vanoc003.jpg align=middle></p></td>
<td width=487 valign=top> <p style=MARGIN:0px align=right><img width=246 alt=[nr20090715vanoc004.jpg] height=62 src=nr20090715vanoc004.jpg align=middle></p></td></tr></table>
<div style=WIDTH:960px> <p style=MARGIN:0px align=justify><br></p> <p style=MARGIN:0px align=justify>
<br><br></p></div></body>
<!-- EDGAR Validation Code: A8C6D1A4 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>nr20090715vanoc004.jpg
<TEXT>
begin 644 nr20090715vanoc004.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`!>`7$#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#UK0=!TB3P
M]ILDNE6+LUI$23;H23L'M6A_PCNB#_F#V'_@,G^%.\/<>&]+_P"O2+_T`5I=
M*J4G=ZF<8JRT,S_A'=$_Z`]A_P"`R?X4?\([HG_0'L/_``&3_"M.BIYGW*Y5
MV,S_`(1[1/\`H#V'_@,G^%)_PCVB?]`>P_\``9/\*H>+/$K>'+&&=+?SVDD\
MO&_;C@G-4?"?C*3Q'>3VSV*P^7'OW"3=GG&.E+GUM<YWB**J^Q>YO?\`".Z)
M_P!`>P_\!D_PH_X1W1/^@/8?^`R?X5IT4^9]SHY5V,S_`(1W1/\`H#V'_@,G
M^%'_``CNB?\`0'L/_`9/\*TZ*.9]PY5V,O\`X1[1/^@/I_\`X#)_A2_\(]HG
M_0'L/_`9/\*T&94!)(4#J36!?>,=%L25:\$K`?=A&[]>E:0C4J.T;LRJ5:5)
M7J-(O#P]HO\`T!K#_P`!D_PH/AW1/^@-8?\`@,G^%<C=?$J-21::>['LTKX_
M05G/\1]7<_N[>U4?[K'^M=<,!B9=/Q.">;X*/6_R/0/^$>T3_H#V'_@,G^%'
M_"/:)_T!]/\`_`5/\*R_"'B.77[:X^TI&D\+`$1YP0>G\C73'FN.I"=.;C+<
M[Z%6G6IJI#9GFWQ4TC3;+P3-+:Z=:0R>=&-\<*H>OJ!7A%?0OQ>_Y$&?_KM'
M_P"A5\]=J]?+W>D>;CE:H%%%%>@<04444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'U?X>_P"1:TO_`*](
MO_0!6E6;X>_Y%K2_^O2+_P!`%:5?*RW9])'9'.ZSXST'P],L&IZ@D4S#(C5"
M[X]P!Q69_P`+6\']]2D_\!I/_B:P;_X-IJ%_/>S^()VFF<NY:`$\_C6?=_!F
MTL[=KBY\1LD*]6-I_P#9UV0IX;E]Z3O_`%Y').IB;Z15C0\4^+O!WB:RBMQK
M[6S1R>8&-I*<\$8^[3?"?BCPMH"S";Q)#.'`"`6<B,OKSMR>U<NWP\T,'CQ4
MY_[A[?\`Q=(/A[HG_0T2_P#@N/\`\76GU;#7O=_U\CEY9^U]KRJ_K_P3U-?B
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MWUL7#*JU=.I!671,P?AM+MU6\B_OP!_R/_V5>FBN`\.>';[P_P"*]LH\VVDB
M9$F4<'H?F]#Q7?\`6O'Q\XSK<\'HSZ'*83IX?V=16:;.$^+W_(A3_P#7:/\`
M]"KYZ[5]"_%[_D0I_P#KM'_Z%7SW7=E_\+YF6/\`XH9Q25W'PPFL'\3OIFHV
MT$\-["8T\V,-AUY&,].,C\JO^$O"\.F^,=:EU:)'L-$21Y/,0$-UV<'U7<WY
M5M/$*$G%]#&-!R2:ZGG%%=7H.M7;:Q?SV'ANTU*\NF\R-6MC(+=<GHH[<C\J
M[S4=/FU[X<ZG>Z]H,&GZE:;GB:.'RR0J@Y]<=12GB>22BT.-#F5TSQD\<4@Z
MUZUX=32++X/RZO?Z/;WSPSDX=`"Y\P!<MC.,FKFA7UAX\\):Y#>Z+96KV468
MF@CQMRK$$>A&VI>+:;=M$[%K#7LKZM7/&B`*0'%>D>`O#VE1>'M0\5ZW`+F&
MTR(8'7(8@#DC^+D@#-9.I_$*?4[.YM7T'28X)5*QE8/GB]"#ZCZ5?MY2FU!;
M&?L4HIR>YQW`I*]3LK#3?`_P^M?$-QIT-_JM\R>2+A=R)O!9>/\`=&?6K/AJ
M?3/B79W^G:KIMI:ZC#'OBN+6/:0.GZ'''?-0\5:[MHBEA]E?5GD=%>H_#K2;
M<Z-XKCOK2"6:U78#)&'*L%DSC/3I6=\(+*VO_%=U%=VT4\8LG(26,.`?,3GF
MK>)2Y]-A+#M\OF<!QFCC;[UZ;X'M].U>_P#$OARZMK??/YS6TIC7<AR5.#^1
M_`U3\%Z9!HNC^(O$&KVD4OV%#:113('#3Y]#[[!^)H>(2OIV_$:H-VU_I'GV
M?EQ1GY<5[#X>\,3Z/X(M]:T_18-5UN]VRH)@I2%#R"`2.WISS3/%7AN35?`<
MVM:AHT&F:W:'=(L`4"1,C/W2>Q^O%1]<CSV^17U9\M_F>04O6O78O[$TGX5:
M/K%YH\%Y.DF8QL`\R3+@;CC)'M["O.O$WB%O$FH1W9L+:SV1B/;`N`?<UI2K
MRJ2=EH9U**@M7J8U%7]&U+^R=22]^R6UWY8.(KE-R$XX./;K7I_@GQ1>>-=4
MN-&UC3+&XL3"7;RX<>5Z?S^M.M5E35[:!3I*H[7U/(:7BNR\'^%[+7O'5S8;
MS+IMH\DF0?\`6QA\*,^^16C=_$VYLM7EM=,TS3UT>&1HUMO)'[Q`<9)]3_G-
M*5=\W)!7"-%6O)V/.Z6O1/'.CZ-I5]H_B.RTU7TS44\Q[/<8TSM!'3ID'H/2
MK^IW&GZE\'KC4+32+33RURD>R%.2%<=3U-3]:NDTMQ^PU:;V/+.E)7I/ANRL
M/#/@"3Q?<V<5W?SR;+-9ERB?-C./^`D_A5OPKXH7QOJG]@>);*TG6Z1_)ECB
M"LC!<\'Z`TGB'JXK1%*@M$WJSRNBK^N:8VBZ[>Z:S[OLTIC#>H['\JH&NF,N
M:-T<THV=@HHHJM1'U?X>_P"1:TO_`*](O_0!6E6;X>_Y%K2_^O2+_P!`%:7K
M7RTMV?21V0&N=\:9_P"$??'_`#T7-=%4%U!!<6[QW,:21=2&'%5"7*TQRCS*
MQXW14NG^*$O?%%O;#3=/6RFN1$%\CG83@<^M=E<W4%M=R10:;8JJ,0/W`SQ1
M6SK#TH<S3-JN28FE-0E;57+/@68R:3/$>D<O'XBNK'K6/H=^MY;NOEQQLAY$
M:X&*V`*SA7AB%[6&S,W2E2]R6Z%ICMM0GT&:?3)!NC8>HJD2]CYXU+QYKEW)
MLM)_[-M5/[N"T_=@?4CDUMZ5\3$$$:Z[I,.H7$0_=W*@!OQR/U%9NC_#?7=3
M43SHNG6W7S+G@X_W.OYXK=3P#X4A_=W?B.:27N80JK_(_P`Z]FM5P4%:3/`A
M'$7O^?\`DSF/$_CC5?$KF.1_LUEVMHCPW^\>]8VF:K?Z/="YT^ZDMY1W4_*W
MU'>O1'^%5A>H7T;7Q(1_#(JO^9'3\JY/6O`GB#1<R36?GPC_`):V_P`X_'N/
MQ%=%"OA9QY(-6,ZM+$)\\OO/4O!/CZ#Q*HLKQ5@U)%SL!^64>J_X5W/:OGKX
M;\_$#3/^VG_HMZ^A:\G&THTJO+`]?`U95:5Y'!_%[_D0I_\`KM'_`.A5\]=J
M^A?B]_R(4_\`UVC_`/0J^>NU=^`_A?,X\?\`Q2>RO)M/O[>]@.)K>02(?<'-
M>M?$?Q-82>%(/[-V"?7/+EN&4\[$`X/Z#\#7CU+TKHJT8SFIOH80K.,7%=3U
M;P!)%<>`-3T[2=1M[#7I)<^9*^TE?EQ@]<8R..A-:=O_`,2_X<^(+#4/$=MJ
M6HLDK$"Z\PI\@^0$\GI^M>*]J7`VY[UD\)>3E?K<U6(M%*WD>F6E[:CX$WEJ
M;J$7)GR(?,&\_OD[=:/A=?6MMH7BE+FYBB>2%`@DD"EODDZ9KS,4=35/#)P:
MON[DJO:2=ME8]+^'VN:3=>&M1\):Q=+:K=$F"9S@<@<9Z;@1GWK'U/X<7VEV
MES=2ZOI1MX4+IBXVM+CL!CJ?K7&'!I!1["49MP>Y/ME**4EL>JV=[IWCGX>V
MOAZ6_ALM6L=GE+.^U)"@*KS]#]<U9\,VMA\-+.^U/6-1M9K^:()!:VTFXL.O
MZG'/08KR+@TE2\+HXWT9:Q&SMJCU/X7:M:W;^(;*]NHX+K4AO4L<!B=^<?\`
M??2M/P'X=L?!_B&XDU#Q#ILET]NT:0QR=$W*=Q+=#P.*\:-(*)X6[=G9,<<3
M9*ZV.@T_6CHGCL:JAS'%>N7Q_%&20?T)KL_BUK5H(K31M-:/RI7:]N#$<AW/
MW?ZG\J\LHZ5I+#Q<U/L9QK-1<>YZYIE_;>,_A]9Z+!K":;J]AL55>3R_,"`J
M/JI4_@17*Z_X8UC1-+FFU#Q%9R\@"VCO&=Y,GT:N-ZT4H89PE[KT'*LI+5:G
MI>MWMM)\%-(MEN8C<+,I,0D7>.9.U>:=J*4]*THTO97,ZE3GL:OAS0I/$>L1
MV"7$-N""SRRM@`#KCU/M7K5[X3N].T/^Q?"EWIMK#,/]+N[BX/GS'TX0X'^?
MKX?16=:C*H[WT-*=906QV_A'4X_`OCR6"_GBDAVFVFGA+,@SALCCG!'\ZO7W
MPPN[S6)+K2[^R?1II&D6Y\X8C0G.#ZX_SBO.J*4J$K\\7J*-56Y6M#O_`(DZ
M_I]VFEZ#I,HFL]+A\LR!MP8[0%P>^`.OO4T4L?\`PHJ>/S%\S[;G;NY^^*\Z
MHJOJZ4%!=-1^W;DV^IZ7X;O+'Q1X`D\(W5W%:7\,F^T:5L*_S;L9_P"!$?C5
MCPMX4/@G53K_`(FO+:WCM4<0Q)*&:1BN.!]">*X&PTJWOECWW\=NY0N_F``#
M#@<<\G!)_#%+;:/#<0>8^HPQ.&".C^^.G/N<_2LG1>JB]&6JJT;6J(-<U-M:
MUV]U)DV?:93(%]!V'Y51)IT\?E3O'\_!Q\ZX/Y4RNR,5&-D<TG=W84444R3Z
MO\/?\BUI?_7I%_Z`*TO6LWP]_P`BUI?_`%Z1?^@"M+UKY:6[/I([(3&,5@>,
MK_\`L[PK?3*<,T9C7ZMQ_6M\\U@^*?#Y\2:4+);HVY$@DW[-V<9XQD>M34OR
MNQT89TXUHNI\-]3Q'1#MU[3SZ7,9_P#'Q7I^HY349QC^,FJ.G?"R2SU*WN7U
M4.D,BR;5@QG!SCK797>@0W5PTS2NI;J`*\3%8*K5H\J6MSZ+'YEAJE=2INZM
MYF+H5U]GU&,$_++\I_I7:"N:?1X;2=6*WDI7#`Q1@CK72#@5U990JT:;A5/"
MQE2G4GS0'4AZ&EHKTSD/']:U&_N[^>*\G9PDA3;T`P?2LRO5=2\+:7J<IFDC
M=)F',D38)_I6/+\/[<G]S?RJ/]M0W^%>55PE7FON>15P=5RON<+%+)#()(I'
MC<='0X(KKM$\:R1E8-3_`'D9X$P'(^H[U-_PKP_]!/\`\@__`%Z</`$<:EGO
MWDP,XCB"D_K13HXBF[H5.AB:;O%&U'X;T6?6+;7K:%%NDR1+"<!\@CD#KUK?
MK#\/V$&GP200+>*A(8_:/?TK<KU.:4DN8]2FK+:QP?Q>_P"1"G_Z[1_^A5\]
M=J^A?B]_R(4W_7:/_P!"KYZ[5[>`_A?,\K'_`,4**WO#FBVNHB_O]2>1--TV
M(2S^5]^0DX1!Z9/>M'24\.^)=132!I1TJ:X^6VN8[AY,/V#A^H/MBNF55*_D
M<RIMV\SD>*.*ZS3]-TW3O"]]J&K:6;RY@U`6?E_:'C`^0D]/<4[28-"N].\0
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MXS%8I(4\P$X+G')`QV]:-%@TGQ#XSTVS&F?8[29MLL"SN^3SR">1VJ'52OY#
M5-NWF<O16GHUG#>>*;"PE4M!->1Q,H.,H7`/Z5OQZ;H]AH6K:A<Z8;Q[?5?L
MD:&=TPF">WTIRJQCH"I-G&T5Z!'X6TB/Q#'OMIGLYM&;45M)I"'B?!.PE<<<
M?K52+1='U72=,U6WLIK!9-5CL9K<S%TE!YRA/(]*CZQ$KV#.*HK3UFS@L_%-
M]80J5MX;R2)%)SA`Y`YKK9_#^AZ=J7BYI;!KFWTKR?(@,[I]\@')'UJI5XJP
ME2;//Z7%=;X>M]$\1>+K&T72&M;0QRF2,73OO(C)'/;I45W8:5J'A"XUBSL)
M-.EMKA8=IF,D=QOSTSSD8H]O%2Y6@]F[73.6HHHK<R"BBB@`HHHH`****`"B
MBB@#ZO\`#W_(M:7_`->D7_H`K2K-\/?\BUI?_7I%_P"@"M*OE9;L^DCLA>U<
MZ!<ZOJ-Z@OI[2TM9/)5+?`:1MH9B20>/FP`/0UT7:N?U#3-0ADN[K1KN.*:=
M,R131;U9PN`XY&&P`.XX'%5$4S$NO$YTV^ET235H)+@R1I'>38_=!]^1)C`W
MC8<=,Y7WJ]JD\GANWCU"36IYHPX$D-T4/G`GYMF`"'`YP...GI3TC1=.D\*^
M?+>A7"(TETP">0\>?E*GI@E\ALYW/G[U9NA:;/<:C91ZO=*+=;<&RB\DKYL:
MR,0O+'''E$KU(V#^%L[<L?N,.:?WF]I5P_B6*6]BUF>*/S72.&U*+Y0!P"^5
M)WD<X/'/3O6OHEU/,EU;7++)/9S^2\JC`D^57!QV.'7/OFN>_LZXMO%SIHMY
M"N8)&N$EB\P0[W!`X8=3O8`]/G[&NETS3ETZ!XR[32NYDEE;J['J?Y#'H!6<
M[&L+FE11169J-)P*Y(^(9]7N+HV#^386LXMFN%4&2>8D#;'NX4`D98@^WK76
MD`BN!U739O"'AWS;5VN+&UU!+QHQ'^\6,OEQGOC.>E732>G4RFVM>AWD:>7&
M$RS8'5CDFGURD'B2[>W,MA;Q:Y;XRLME.@<>@=3P#]#^`J?PY+K=[=WU]JMD
M+"*41QV]J9`[J%WY8D<9.X?E0X-*[&JB>B.EHHHJ#0X+XO?\B%/_`-=H_P#T
M*OGNOH3XO?\`(A3_`/7:/_T*OGKM7M8#^%\SQL?_`!3JO"5S:W&FZWX?N;B.
MV?4XHV@EE;:GF1OD`GMGUJUH'AJ]T+7+;5M>46%A8R"8O)(,RL.0D8!^<DXZ
M5QE(.:Z)46[V>Y@JJ5KK8[N#Q%>V_@S5M1L;DVMW<ZR)"$/.'1B?PJOX8U:[
MLO#/BR^BNC%>D6[K*#\Y)EY_F:XRBE]75F@]L[IG7^%+Z6ZN/$]U>3[YYM%N
M-SR'EC\E326C>,/"^E1Z;)&^JZ9&;>2S=PCRQYRCIGK[UQ5%#H>]S1$JNEF=
MIX9T*_T+QIHDFJ11VV^XX1I4WC"]2`<@?6EM;C3]%T'4;F^@DN7U>Z>!(X9Q
M&XBC.2=V#P7P/PKBJ*'1YG>3*56RLD>D">TUC5?!VO6JF$1W,=A<)+*'9/+(
M*$G`W97OCM7->)]`U2RU'4-0FM@MI)=.4D$B'.7..`<USE%$*+@]&$ZJDM4;
M?AW3]>N+AKW0/,^T0$9,4H#<^V<D5V-W?V=AXP\,:AJ:V]OJHW'5?)QL4YPA
M?'`?#9->9T43H<\KLF-7E5D=QI?A34],\46VJ7HA@TNTN1<->M,IC=$;/!SS
MG'`]Z?;:_<6?@W5K[3KCR)I]9#CH3L*,>A_"N%Q24.A?XF4JUOA.Q\%ZI<R^
M)=0U"ZNWDN3IUP?-E?))V\=:S;+6]1U;Q-H[ZE?23)%=P[`YPBC>,X'05@45
M7LHW;)]J[)'7^*?#VIV_B34M5DMA]A:_:02B9#D&3@XSGN*ZMIKPZ]XZ.D3@
M7S^1]G*2`$_,,X)XZ9KR6BH=!M6;_K3_`"+59)Z(]!\,P:Q9?$?3KW7FQ/-'
M+^]DD0YQ$1V/TJG>WL_C'P>)IKAWU31LF1"W^O@)^_CU!Z^U<513]AKS]1>V
MTMT"BBBNDP"BBB@`HHHH`****`"BBB@#ZO\`#_\`R+>E_P#7I%_Z`*TZQ++3
M-8L;&WM4U*P98(UC!-B^2%&/^>M6/L^M_P#01T__`,`7_P#CM?+-*Y](F[;&
MG169]GUO_H(Z?_X`O_\`':/L^M_]!'3_`/P!?_X[18+OL+-HFEW%Y]KFTZTD
MN,@^:\*E\CIS5B[L+6^@\F[MHKB+.=DJ!Q^M5?LVM_\`01L/_`%__CM'V;6_
M^@C8?^`+_P#QVG\Q?(M6=C:6$'DV5K#;Q9SLB0(,_A5FLW[/K?\`T$=/_P#`
M%_\`X[1]GUO_`*".G_\`@"__`,=I#N^QIT5F?9];_P"@CI__`(`O_P#':/L^
MM_\`01T__P``7_\`CM%@N^QITUE!4@C(/:L[[/K?_01T_P#\`7_^.T?9];_Z
M".G_`/@"_P#\=HL%WV+D%M#;1B."*.*,?PQJ%%3UF?9];_Z".G_^`+__`!VC
M[/K?_01T_P#\`7_^.T!=]C3HK,^SZW_T$=/_`/`%_P#X[1]GUO\`Z".G_P#@
M"_\`\=HL%WV.5^+W_(A3C_IM'_Z%7SU7TMXE\*:CXHT5]-N]6M(D9U??%8MG
MCZRFN*_X45_U,?\`Y(__`&RO3P>(I4H<LG^9YV*P]6I/FBCQZBO8?^%%?]3'
M_P"2/_VRC_A17_4Q_P#DC_\`;*Z_KM#^;\&<OU.O_+^*/'J*]A_X45_U,?\`
MY(__`&RC_A17_4Q_^2/_`-LH^NT/YOP8?4Z_\OXH\>HKV'_A17_4Q_\`DC_]
MLH_X45_U,?\`Y(__`&RCZ[0_F_!A]3K_`,OXH\>HKV'_`(45_P!3'_Y(_P#V
MRC_A17_4Q_\`DC_]LH^NT/YOP8?4Z_\`+^*/'J*]A_X45_U,?_DC_P#;*/\`
MA17_`%,?_DC_`/;*/KM#^;\&'U.O_+^*/'J*]A_X45_U,?\`Y(__`&RC_A17
M_4Q_^2/_`-LH^NT/YOP8?4Z_\OXH\>HKV'_A17_4Q_\`DC_]LH_X45_U,?\`
MY(__`&RCZ[0_F_!A]3K_`,OXH\>HKV'_`(45_P!3'_Y(_P#VRC_A17_4Q_\`
MDC_]LH^NT/YOP8?4Z_\`+^*/'J*]A_X45_U,?_DC_P#;*/\`A17_`%,?_DC_
M`/;*/KM#^;\&'U.O_+^*/'J*]A_X45_U,?\`Y(__`&RC_A17_4Q_^2/_`-LH
M^NT/YOP8?4Z_\OXH\>HKV'_A17_4Q_\`DC_]LH_X45_U,?\`Y(__`&RCZ[0_
MF_!A]3K_`,OXH\>HKV'_`(45_P!3'_Y(_P#VRC_A17_4Q_\`DC_]LH^NT/YO
MP8?4Z_\`+^*/'J*]A_X45_U,?_DC_P#;*/\`A17_`%,?_DC_`/;*/KM#^;\&
M'U.O_+^*/'J*]A_X45_U,?\`Y(__`&RC_A17_4Q_^2/_`-LH^NT/YOP8?4Z_
C\OXH\>HKV'_A17_4Q_\`DC_]LHH^NT/YOP8?4Z_\OXH__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>nr20090715vanoc001.jpg
<TEXT>
begin 644 nr20090715vanoc001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`"6`?0#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#WVBBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBO.?B)\1KO
MP9JMI9VME!<>=#YK&5F&/F('3Z5<(2F^6),YJ"O(]&HKPY?CS?!1NT*W+=R)
MV`_E5A/CXP0;_#8+=R+W`_+RZV^J5>QC]:I=SVFBO&!\?!N&[PT0.^+[/_M.
MIO\`A?5O_P!"_+_X%#_XFE]5K=OR']9I=SV&BO'O^%]6_P#T+\O_`(%#_P")
MIC_'N(#]WX==C_M7@'_LAH^JU>P?6*7<]DHKQC_A?G_4M?\`D_\`_:Z@D^/5
MR7)C\/Q*O8-=$G\]HH^JU>P?6:7<]NK*UWQ%I7ANR^UZK>)`AX13RSGT51R:
M\DB^-^M7=TL-GH%O)(_"1J[NQX]NM>9Z[KNH^(]5EU#4IFEF<X"_PH.RJ.P%
M:T\')OW]$9U,7%+W-3U;5?CNH=DTC1BRC[LMU)C/_`%_^*K(E^-?BR(!WTK3
M(T;[I>"49_'?S7;?#?X<V>AZ9!J>J6JRZM,H<"5<_9P>B@'^+U/X#W[Z^L+7
M4[*6SO;=)[>5=KQN,@C_`#WI2J4(2Y5&XU"M)7<K'AUK\=M;1P;O2M/E3/(A
M+QG'U):O0_"7Q/T3Q3.EG\]EJ#_=MYCD.?\`98<'Z'!]J^>_$FEKHGB74=,1
MBR6UP\:$]2N>,_ABLU'>*19(V9'4AE93@@CN#75+"TIQNE8Y8XFI"5I:GV;1
M7/\`@G6)=?\`!NEZE.<S2Q;9&_O.I*L?Q*DUT%>5).+:9Z:=U=!1112&%%!.
M!DUSFI>//"VDN4N];M`XZI$QE8?4("1347+9";2W.CHKSR7XT>$HR=CWLO\`
MN6^,_F14UK\8?"%S*J-=7,&X@9EMVQ_X[FM/85/Y61[:G_,CO:R=7\2Z+H`7
M^U-2M[5F&51V^8CU"CG'X4>)M8_L#PUJ&J[0S6T)9%/0MT4'VR17FGV"[T.V
M\/7OFVDNOZ_-NNM1OH1*8MRA@%!("@`@<>GI@4Z=-2U83FUHCTK2/$^B:]N&
MEZG;W+J,E$;#@>NT\UKUY%]DG\3IK['["FO:`R26FK:8I03DJ6V-Z_=P?3/Y
M^B^%M9/B#PQIVJLNQ[B$,ZCH''#8]L@T5*:CJ@A/FT9L4445B:!114<\\-M"
MTT\J11(,L[L%51[D]*`)**XK2?B5I&M^,_[`L%:6,Q,R7>["NZ\E57&2,9.[
MVZ8YKM:J4)1TDB8R4M4%%%,=UCC9W.%4$D^@J2A]%<@/BAX,(!_MR+G_`*8R
M?_$TO_"S_!G_`$'(O^_4G_Q-:>RJ?RO[B/:0[G745S^D>-O#NOW_`-ATO4TN
M;G89-BQN/E&,G)`'<5T%0XN+LT4FGL%%%8^N>)]&\-BW.KWJVHG+",LC-NQC
M/W0<=1UH2;=D#:6K-BBN1_X6?X,_Z#D7_?J3_P")H_X6?X,_Z#D7_?J3_P")
MJ_95/Y7]Q/M(=SKJ*XY/BGX+=B!K:9'K!*/YK5^R\=>%M0<);Z[9;CT623RR
M?H&Q2=.:W3!3B]F=%13$=9$#HP96&05.013Z@L****`"BBN)\7?$S1?"I%NK
M"_OMP#6\,@_=C/)9L'!]NOTZU482F[11,I**O([:BF12QSPI-$X>.10RL.A!
MY!I]24%%%%`!1110`4444`%%%%`!1110`5\U?%S5EU/Q]<QQN&CLHUM@1ZC)
M;\F8C\*^E:K1V-G#,TT5I`DK,69UC`8D]23Z\FMJ%54I<S5S*M3=2/+>Q\A0
MV%Y<8\FTGDSC&R,GKTZ"KT7A7Q%,NZ+0=4=<XRMG(1G\J^N**Z7CGTB<_P!2
M7<^0=3T'5M&6-M3TZYM!*2$,\97=CKC/U%9]>N_'B]WZIH]@"/W4+S$?[S`#
M_P!`->15VTIN<%)G'5@H3<4%:>F^'=:UB!I]-TN[NXE;8SPQ%@&QG&1WP1^=
M9E?3/PHT\:?\/-/)!#W)>X?_`($QQ_XZ%J*]7V4;HJA2525F?/DOA;Q#"`9=
M!U2,'IOLY!G]*SYK.ZMQF:VFC'JZ$?SK[(HKE6.?6)U/!+N?-OP>M5N/B':R
M,`?L\,LHSZ[=O_LU>CZG\)[:Z\>VFMVI@BT[S1-=VK9Y<'/RC&,,<9!([^N*
M]#2RM([C[0EK`LV,>8L8#8^M6*QJ8F4I\T=-+&L,/&,>5Z]0HHKF/'?BB+PI
MX8N+OS%%Y*IBM4[M(1UQZ#J?I[UA&+DTD;R:BKL^=/&EXE_XUUFYC;=&UW(%
M;U`.`?R%8=!))))R3U-=U\.O`%SXJU*.\NXFCT>!P978$><1_`OK[GM]:]MR
MC3A=[(\91=2>G4]K^'-A)IOP^T:WE4JYA,I!ZC>Q<?\`H5=335544*H`4#``
M&`*=7B2ES2;[GLQ7*D@KA/&?Q/TGPJSV<`%]J8X,$;86,_[;=OH.?I7.?$SX
MGM8/-H6@3XN@2EU=I_RS[%$/][U/;MST\/9F=BS$LQ.22<DFNS#X7F7-/8Y*
M^*Y?=AN=%XB\<^(/$SL+^_=;<GBVA^2(?@.OXY-4]!\,ZOXENS;Z5923D???
MHB?[S'@5L^`?`UQXRU0AR\.FP$&XG`Y/^PO^T?T'/H#](Z5I%CHFG16&G6R6
M]M&.%4=3ZD]R?4UO6KQH^[!:F-*A*K[TWH>06'P'N'A#:CKD<4I'W(("X'_`
MB1_*G7OP&E6$FQUY'E'1)[<JI_X$&./RKVNBN+ZW5ON=?U:E:UCG=7T*ZU;P
M%-HES,CWLEFL;2C[K2J`<\]BPKA(''C6/POIMQ9QM=Z1<&+5;*=E5E55"[MK
M$%@<=LXKUVL36?".@>()5FU/3(IYE&!*"4?'8;E(/ZU-.KR[ESA?8X*6:3P#
M+XDTBU@+Q:BZ'1;2*178R.N'&S)8`'')&#MZUWWA+1WT#PIINERD&6"$"3'3
M>>6`]LDTS1O!_A_0)FGTS3(H9SUF8M(_X,Q)'YUNT5*BDK((0:U84445B:!7
MEOQJ,=WINC:/#'YFHW=X/(4'MC:>/<LH_.O4J\JT[/B_XU7=\?GL-!C\F/T,
MG(_]"+G_`("*WH:2Y^QE6UCR]SR"RGN_!WC**208N--N]LBJ?O;6PPSZ$9'X
MU]80S1W$$<\3AXY%#HPZ$$9!KY[^,^B_V=XR6_1,1:A$),@<>8ORM^FT_C7I
M_P`)]:_MCP):QN^Z:Q8VKY/.%Y7\-I`_"NC$^_3C41SX?W*DJ9W--95=2K`%
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MSUJ;X]H#;Z$_\0><#Z$)_A6E\"XU'@^_EYW-?LI^@C3_`!-=[F_JJ=_ZN<*B
MOK+5CNG\+^'Y$*/H6FLIZ@VD?^%<KKGP?\,ZK$QLXGTVX/1X"2F?="<8^F*]
M!HKBC5G%W3.N5.,MT?-ER?&'PIUA8%N6%LYW1X)>WG'?@]#Z]",_C7M'@CQS
M8^,].+Q@07\0_?VI;)7_`&E]5/Z=#[W/&'AN#Q5X;N=-E5?-*[[>0_\`+.0?
M=/T['V)KYI\.ZU=^$_$MO?QAEDMY-LT73>N<.A_7\<'M7:E'$P;^TCE;>'FE
M]EGUK145O/'=6T5Q"P:*5`Z,.ZD9!J6O/.TR_$=Y;:?X:U.ZO%#6\=M(70G&
M\;2-N??I^-?*E[H]Y8:;I]_<1[;>_1W@/J%;:<_YZ$5[G\7;^:ZMM*\*V3?Z
M5JMRN\`]$!&,^Q8@_P#`32?%3PS"/AO;K:1\:/Y?EXZ^7@(W]"?I7=AI>S2O
M]IG'B(>TO_=1K_"K6O[8\!V:NVZ:R)M7SZ+]W_QTK^5=M7@?P0ULVGB2ZTB1
MOW=]%O0?]-$R?_02WY"O?*PQ,.2HT;8>?/33"BBBL#8****`"BBB@`HHHH`*
M***`"BBB@`HHH)P,F@#YG^+-_P#;OB'?A3E+94@7\%!/_CQ-<35[7+[^U-?U
M"_\`^?FYDE'T9B15&O=IQY8I'B5)<TVP52S!5!))P!ZU]@Z39#3-'L;`8Q;6
M\</'^RH']*^6_!>G_P!I^-='M"NY7ND9QZJIW-^@-?6-<..EJHG;@HZ.0444
M5P'<%9?B'5UT'P]?ZHR!_LT+2*A.-S?PC/;)P*U*JW^GVFJ64EE?0)/;28WQ
MOT;!!&?Q`IQM=7$[VT/&;KX\WKP;;30H(IL<O+<&1<_0*O\`.O-]:\0:EXGU
M47>KWI=R=H)'R1+GH%'0?3D^YKZ2N/A[X2N8&A?0;-5((W1IL8?\"&#7@_Q$
M\%'P;K:10.\EA=*7MW?J,?>4GN1D?@17I8>=%RM!69Y^(A54;R=T=7X'\)>`
M+F>)[OQ##J=V<%;:0&W3/IM;!?\`/\*]OAABMX4AAC2*)!A410%4>@`Z5\:U
M[+\&_&E[<WS>'-0G>>,QE[1W.63;U3/IC)'IBIQ5"37/>]BL-7C?DM8]IKSK
MXJ>.3X:TL:9I\N-4O%X9>L,?0M]3T'XGM7<:KJ5OH^E76HW;;8+:,R/ZG'8>
MYZ#ZU\G:[K-UX@UJZU2\;,UPY;&>$'0*/8#`_"L<+1YY<SV1MB:O)&RW9GDD
MDDG)/4U>T;2;K7=8M=,LUW3W$@1<]`.Y/L!DGZ51KVSX(>&Q':W7B*>/YY2;
M>V)'11]]A]3@?@:]"M4]G!R//HT_:32/3O#^AV?AS1;?3+),10KRQ'+MW8^Y
M-:E%%>*VV[L]A*RL@HHHI#"BBB@`HHHH`****`,3Q;K8\.^%M0U0D!X8CY6>
M\AX7]2*YWX2:(VE^"X[R8'[3J3FY<MUVGA/T^;_@587Q?N[K6-0T?P?IH\RZ
MN7\]TS@=PF3Z??)^@-2P0?%NVMXK>%=+2*)`B*-G"@8`KJC3_=6NE?N<[G^\
MO:]C0^,VC?VEX+^VQKF73Y1+Q_<;Y6_F#^%</\#]9-IXDN])=OW=[#O0?]-$
MY_\`02WY"NDOK/XL:C87%E<II;P7$;12+E!E6&#_`#KR+3+JZ\*>+K>>5"EQ
MI]UB5`?[K8=?Q&1712A>DZ=TS"K+EJQJ6L?6U%,BECGA2:)P\<BAE8="#R#3
MZ\T[SE_B/_R3S6O^N'_LPKQ?X-_\E"M_^N$O_H->T?$?_DGFM?\`7#_V85XO
M\&_^2A6__7"7_P!!KOH?[O/^NAQUOXT#Z0HHHK@.P****`/'OCU_QYZ'_P!=
M)OY)6I\#/^1)O?\`L(O_`.BXZR?CT1]DT(9Y\R;^25?^!3L?"VHH3\HO<@>Y
M1<_R%=S_`-U7]=3C7^\GJE%%%<)V!7RU\2;-+#XAZS"@`5IA+QZNH<_JU?4M
M?*_Q#OEU'X@:U.I!47'E`C_8`3_V6NW`WYWZ''C/@7J?0'PZN&NOA]HLCDDB
MW\OGT4E1^@KJ*YSP%9M8^`]%@<8;[*LA&,8W?-_[-2^.==_X1SP?J&H*^V?R
M_+@YY\QN%Q],Y_"N:2YJC2ZLZ8OE@F^QQ?AO/B_XP:KKC?/9:0GV:V/4;N5!
M'M_K&_$5Z9J%E%J6G7-C.,PW$31./9A@_P`Z\7\&Z+\1M(T&-]$AL([6\Q<@
MS%"[;@,9SSTQQ[UT/_%W_P#J%_\`CE=%6G>6DEIYF-.=HZQ>IXU8W%SX4\71
M2N,3Z=>8D7UVMAA^(!'XU]9Q2QSPI-$X>.10RL.A!Y!KY<\=Z/KVG:Z;OQ!#
M"EU?#S=T&-C$8!Z=^A/UKW+X6:U_;/@.RWMNFL\VLG_`?N_^.E:TQ:YH1FC+
M"OEG*#.THHHKSSN"BBB@`HHHH`****`"BBB@`HHHH`*Q/%U__9G@_5[S<5:.
MTDV$?WBN%_4BMNO//C-?FS\`O`K8-Y<1PD=R!E__`&05I2CS32(J2Y8-GSI1
M117N'BGHGP6L/M7CK[21\MG;229]VP@_1C^5?15>/?`>PVV6L:BR_P"LDC@5
MO]T%F'_CRU[#7D8N5ZK\CU<+&U-!114-S<0V=M+<W$JQ01*7>1S@*!U)KF.@
MFHKCO!7CJ+QGJ&LQV]MY5K9/&()&/S2JV[DCM]W]:[&JE%Q=I$QDI*Z"O)OC
MN(_[!TIB!YHNF"GVV\_TKUFO!/CAK<=YX@L](A<,+&,O+CL[X./P4`_\"K;"
MINJC+$M*DSRRNW^$<3/\2=-9>D:3,WT\IA_,BN(KV;X&^'9%:]\0S)A&7[-;
MY'WN078?D!GZUZ6(DHTW<\_#Q<JB)OCCXB,5M9^'H'P9?](N`#_"#A!^8)_`
M5XG6]XTUH^(/&&I:@&+1/,4A_P"N:_*OZ`'\:P:="GR4TA5Y\\VQT43S3)%&
MI:1V"JHZDG@"OKC0],A\/^';+3E95CM(`K.3@$@99OQ.37RSX<O[72O$-EJ-
MY$TL-K)YWEKU=EY4>WS`<^GK6SK'B;Q3\0-1-NJW$Z,<QV-HK%%'J0.N/4_I
M66(I2JM*]DC3#U(TTWNV>[:E\2/".ENT<VM0R2`XVVX:7GZJ"/UK('QF\(E]
MOFW@&<;OLYQ]>M>+7O@'Q5I]JUS<Z'=+"@RS*`^T>I"DD"N<J(X2DUH[ERQ5
M5/56/JG2/'WA?6Y5ALM8@,S8`BES$Q/H`P&3],UTM?&->F?#GXFW>CWL.E:S
M<-/I<A")+*V6MST!R?X/;MU'H<JN#LKP9I2Q?,[31]!44`Y&117"=H4444`%
M-=UC1G=@JJ,LQ.`!ZU'<W,-G:375Q((X(4:21ST50,D_D*\P^(7Q,T8^%[FP
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M7>I2^)+!/AYK18X'D`?FP%>,_!O_`)*%;_\`7"7_`-!KT#XA>.O#6I>!]2L;
M+5H;BYG5%CCC#$D[U/IQP#7F/PQUBPT/QI#>ZE<K;VRPR*9&!(!(XZ`UT482
M5"2:,:TDZT7<^GJ*Y?\`X6/X/_Z#UK_X]_A36^)/@]5+'7K;`]`Q_I7#[*?\
MK.SGCW-[4]1M])TNYU"[?9!;QF1S[`=![GH*YOX<:UJOB+PW+JNJ2!C/=2&W
M4(%"1`@!>`,X.X9//%>4_$SXD)XGVZ5I)==+C;=)(PVF=ATXZA1Z'J>>PKUC
M2K_1_`WA+1+#5KV*S<VXP),_,^`7Z?[3?K6TJ+A35UJS&-53F[/1'#?'S_F7
MO^WG_P!I5I?`G_D6M3_Z_/\`V1:Y+XP^)]+\0WNE1Z5>I=1VT<A=D!P"Q7C)
M'^S3OA+XXTWPW]MTW5I3!!<NLL<^TE58#!#8YYXY]JZ73D\-RVU_X)@IQ6);
MOI_P#Z`HK!'C7PN8?-_X2+2]N,X^U)N_+.:YG7?C%X;TR%EL'DU.YQ\JQ*50
M'W8C^0-<,:4Y.R1V.I"*NV=!XW\40^%/#5Q?%U^U.#':H>K2$<<>@ZGZ5\\>
M#/#=QXO\406?S&'=YMW+_=C!^;GU/0>YK7-AXO\`BIK8O6MV$'W5E8%+>!<]
M%)Z_ADFO<O"'A"P\'Z1]CM/WDSG=/<,,-(W]`.P_Q-=?,L/!I/WF<MG7FF_A
M1OHBQQJB*%10`H'``KR?XF3/XF\:Z#X-MV)C,@GN@N>,Y_4(&/\`P*NTU7X@
M>&-%EN8;S5(Q<6^0\"*6?=_=`QUKR?P#XKTN3X@ZMXB\074=M+<1L8"X)"DL
M.`?91@>U94*<E>I;;8UK3B[0ON>^1QI%$D<:A40!54=`!T%/K/TG6M-UVT:Z
MTN[CNH%<QLZ9P&`!(_(C\ZT*YFFG9FZ=]CS;XTZ/]O\`!R:@B9ET^8.3_P!,
MV^5OUV'\*XSX(:Y]C\176CR-^[OHM\8_Z:)D_JI;\A7J/C77O#]II-]I&KZA
M#!+=6;[8V!+$$$`@`>H./I7S1I&ISZ-J]IJ5MCSK:595!Z'!Z'V/3\:]##Q<
MZ+@SAKR4*RFC["HKD-)^)GA;5HK?9J2P7$Q""WF4APQXV],'GN*Z^N"4)1TD
MK'=&2EJF%%%%2,****`"BBB@`HHHH`****`"O%/CQ?YFT?3@?NK)._XD*O\`
M)J]KKYL^,%_]M^(5S&#E;2&.`'\-Q_5S75@XWJW['-BI6I^IPE%%%>L>6?2O
MPCL/L7P\LG(PUR\D[#'JQ4?HHKN:SM!L?[+\/:;8;=IM[:.(CW"@']:T:\*I
M+FFV>W"/+%(*\*^-'B35FU0:`86MM-"K*&S_`,?)]<^@.1CU&3VQ[K61XA\-
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M/^X.OXDCVJH3HT%H[LF<*U9ZJR/*_`_P]U'Q?=),ZO;:4C?O;DC[_JJ>I]^@
M_0^[>));;PG\/;_[#&((K2T,4"C^%C\J_P#CS`^]=''&D,:QQ(J1J-JJHP`!
MV`KSKXV7GV?P,D`;!N;M$(]0`S?S45@ZKKU$GL;JFJ--M;GSS1117JGEE[1M
M)NM=UBUTRS4-/<.$7/0>I/L!DGZ5]2>%_"VG>%-)2QL(ANP#-.1\\K>I/\AV
MKS'X%Z$K2:CKTJ9*8M8"1T)^9S]<;1^)KVJO,QE5N7(MD>EA*24>=[L*^;/B
MWH,&B>-'>UC$<%]$+@(HP%8DA@/Q&?QKZ3KPCX[L/^$ATM<\BU)Q_P`#/^%1
M@VU4L5BTG3N>44445ZQY9]0?#35GUCP%ILTKEIH5-NY/?8<#_P`=VUUU>=?!
M5&7P%EB<-=R%?884?S!KT6O#K)*I)+N>S2=X)OL%%%%9FA#<VT-Y:36MQ&)(
M)D:.1#T92,$?D:Y^/X>^$8L[=`LCG^\F[^==-15*4ELQ.*>Z.7?X=^$78L=`
MM`3_`'00/R!KID58T5$&%48`]!3J*'*4MV"BEL@KF&^'GA%Y"[:#:EB<G@]?
MSKIZ*%*4=F#BGN<VW@'PFRE3X?L,'CB("I]/\'>'M+%Q]ATJ"#[1$89=N?G0
M]5//2MVBG[2>UQ<D5T.83X=^$8V#+H%F3_M*2/R)J7_A`O"?_0OZ?_WY%=%1
M1[2?=AR1['-OX`\)NI4^'['!](L'\Q4?_"N/!_\`T`;7_P`>_P`:ZBBCVD^[
M#DCV.7'PZ\(*P(T&UR.1][_&M/6?#FC^(/)_M:PBN_(W>7YF?EW8SC![X'Y5
MJT4N>3=[ARQVL<U'\/\`PE&NU=`L2,Y^:/=_.F-\.O"#,6.@VF3Z`@?H:ZBB
MG[2?=AR1['+_`/"N/!__`$`;7_Q[_&K5GX,\,Z>0;;0K!6'1F@5F'XG)K>HH
M=2;W;#DBN@T`*`J@``8`':G445!1SUWX'\,W]])>W6C6TUQ*V]W<$[C[\U')
M\/\`PE(,-H%D/]V/;_*NEHJ_:3[LGDCV,_2=%TW0K1K72[2.U@9S(R)G!8@`
MG\@/RK0HHJ6V]64E;8Q=7\)Z#KUTEUJFF0W4Z((U=\Y"@DXX/J3^=54\`>$X
MU"C0+$C_`&H\G\S7244U.25DR>2+Z'-1>`/"D-REQ%H=JDL;AU901M8'((Y]
M:Z6BBDY.6[&DEL%%%%(84444`%%%%`!1110`4444`%?(7B'4#JWB/4K_`#D7
M%S)(N/0L<?IBOJ+Q?J/]D^#]6O=V&CM7V$?WR,+^I%?)E>A@8[R.#&RVB%:O
MA>Q_M+Q7I-D1E9KN-6_W=PS^F:RJ[KX067VOXB6DFW<MM%),?;Y=H_5A7;4E
MRP;.2FN::1]*4445X1[04444`%%%%`!1110`5Y'\>&(TC1UYP9Y#[?='^->N
M5Y7\=+1I/#&GW0Y$-WL;Z,IY_P#'?UK?#?Q48XC^&SP6BBBO9/(/IOX5V`L/
MAYIG&'G#SN?7<QQ_X[MKLZR?#$(MO"FCP@8\NRA7'T05K5X51WFV>W!6BD%?
M./QEO_M?C^6`-D6EO'#^)!?_`-GKZ*FFCMX))IF"1QJ7=CT``R37R+KVJ-K6
MOW^I."#<SO(`>P)X'X#`KJP4;S<NQRXR5H)=S/HHKI_`/AEO%/BNVM&0FTB/
MG73=A&#T_$X'XUZ4I**;9Y\8N321]`?#W3&TCP'I%JZ[9##YKC'.7)?GW^;'
MX5T](`%````%+7A2ES2;9[<59)!1114C.;\61:U'87&HZ7K?V%+6UDD:`VJ2
MB1E!;JW(Z8KD_`]YXL\9:`^J2>*7M'6=H1''80LO`!R<C/?]*[SQ+_R*NL?]
M>4W_`*`:X#X-:G86G@F6.YOK:%_MDAVR2JIQM7G!-=,/X3:6M^QC+^(E<6X\
M;^(/!7B6WTSQ8;:\T^Z.8K^"/RR!G!)7IQQD=L]33O'/BKQ3I'BO2+&%(+32
M[NZ14GC(D>8;EW`Y'R]1P!^)K`^(]_'X^\3:3X?\.D7K6Y?S;B(;HUW%03NZ
M8`7)/3FMCXMM%I]UX/>5]L-O=DLY[*ICR>/85K&,>:-UJ[F3E*TK/16/5Z*X
M*_\`B:FFE+FZ\.:Q%I3L%%[)#M'/0[3R!Z9P3Z5UD^MZ;;Z)_;,MW&NG^4)A
M/V*GH1WYR.*Y'3DK71TJ<7LS1HKA-4^)/]DP07]UX;U2/29V4)=OL!((R#LR
M2..F<9K;\0^,=(\-:3#J-]+(T4XS`L499I>,\=AP>Y%/V4]--Q<\===CH**\
MVN?C#IR)8-9Z5>7GV@)YICQB%F_@ST9QGIQ6G=?%'P]:Z_)I`:XEEBW*[I$2
M/,!P(U'WF8GC@8]Z?L*G87M8=SMJ*X4?$JWM=7@LM:T74='BN3B"YO%"H?\`
M>Y^7J/7&>:;?_$Q+.#[='X<UB?2`<F_$6U"N?O*#SM/8G&:/8S[#]I'N=Y16
M;'KNF2Z"NMB[0:<8O.\]N`%]_?MCKGBN6U+XD?V=81:JWAW4WT:4KMO3L7<#
MC#!"<X.1@G&:F-.4G9(;G%*[9W=%4/[8L%T5=8>X6.P:`7'G/P-A&0?R(XKE
M;_XBR6.FC6#X:U-M%)4?;"44D$\,(R=VT\8)QG(]:(TY2V0.:6YW-%<W=>.-
M$M/#EIKAFDDM[S"VT4:9EE8\;57USD>GO6=/\0?[*OK*'Q!H=YI4%Z=L-Q)(
MDB@^C[3\O4?3\Z%2F^@G.*ZG:T5RE]XZM-/\4VOA^XTS4DN;J41PS&-/*<$X
MW`[LD#Z9J;Q7XRMO",237NFZC/;L!^_MHT:-6).%8E@0>/2CV<KI6W'SQLWV
M.EHKC?%OC671/"<6IV.F7<\]S`)8_P!RQC@!`.Z5AP,9'&>3^=8W@;QO.WA_
M3+6]T7Q#<3.3YNH?9-T!W.3O+[ON@'DX[<"J5&3CS$NK%2Y3=\)^/;/Q;JFH
MV5M97$!L^=\F,.-Q'0=#QTKKJY'PWXUT/Q!XBO=.T:!B8XS-+<^4(UD.X#IU
M/7J:OZMXI@T_4DTJSM+C4M5=/,^R6V!L7^\[,0J#ZFB<'S62L$9+ENW<WZ*Y
M'0_'EMJGB*;P]>Z==:9JT8)\F;:P8`9X93@\<^A'0FB\\<C;=OHVC7NKPV;%
M9[BW*K$".H4DY<CV!I>RG>UA\\;7.BU.2^ATV>33+>*XO57]U%+)L5C[G'^?
M;K7#_#+Q-KGB6_\`$#ZTZ*;>2*..W10JPGY]P'<]!U)Z5U/A;Q-9^+-$34[)
M)(T+F-XY!RK#&1QUZBN*^$O_`"&?&/\`V$!_Z%)5QC:$TUJK?F0W><6GH>H4
M5Q<OCYI8+J]TK0+_`%+2[5F66\B9%4[?O%%)W.!Z@=JZ71]5MM<TBUU.S+_9
M[E-Z;QAA['W!R*SE"45=FBDGHB_1114%!1110`4444`%%%%`'FOQKU/[)X*C
MLE;#WMRJE?5%^8_J%KY[KU+XY:I]I\36.FJV4M+?>P]'<\_HJ_G7EM>QA8\M
M)>9Y6*ES5'Y!7KGP'L]^JZQ?8_U4"0@_[[$_^R5Y'7O7P+M/+\+ZC=D<S7FS
M\%0?U8T8IVI,,*KU4>J4445XYZH4444`%%%%`!1110`5@>,]"_X23PEJ&F*`
M9I(]T.?^>B_,OTR1CZ$UOT4XMQ=T)I-69\921O%(T<BE74E65A@@CJ#25[I\
M3/AA)JL\FN:#&#>-\US:C`\W_:7_`&O4=_KU\.G@FMIW@GB>*5#ATD4JRGT(
M/2O:I58U(W1X]6E*F[,^K?!E_'J?@S1[J-MP-I&C'/\`$HVL/S!K>KYD\$_$
M?4O!J/:K"EY8.V\P.VTJW<JV#C/T-=3JWQUO)[5H]*TB.UE88\Z:7S-OT7`&
M?KGZ5P3PE3G?+L=\,53Y=7J=%\8?%\>F:(V@VLH-[>KB8`\Q0]\^[=/IGVKP
M&IKR\N=0O);N[F>:XF8O)(YR6-;_`(9\":]XJE4V5HT=KGYKJ8%8Q]#_`!'V
M&:[J<(T86;.*I.5:>B,*PL+K5+Z&RLH'GN9FVI&@Y)_SWKZ=\">#;?P=H8M@
M5DO9L/=3#^)NP'^R.WXGO2>#?`FE^#;0BW!GOI%Q-=N,,WL!_"OM^9-=57!B
M<1[3W8[';A\/[/WI;A1117(=04444`9?B7_D5=8_Z\IO_0#7F_P=T/1=6\'3
MS7^D6-U,EZ\?F7%LDC8V(<9()QS7>>*+#7M4L9+'2;C3X(+B"2*=KF-V<;AC
MY-IP.">H/:N=\$^$/$W@Z#[#'?Z5/827/G3!HI/,Y`#;3D#.%'4&NB#2I-7U
M,9)NHG;0[BRTZQTV(QV-E;VL9ZK!$J`_@!7G'Q;`;6/!ZL`0;\@@]_FCKU&O
M/O%W@_Q)XGUBRN5OM+AM]/N#-:H8I"QY4_.<\_=[8J:$DJG-)CJIN%DC<^($
M:2>`-;5U#`6K-@^HY!_,"N:T'3M)U?X+Z;'KT[1:?$AEDD5]N`LC8Y_3_P"O
M70^(-*\1ZUX9&F)<:5%/<Q-'>N8Y"O/3R^<CO][-8*^`]<E^'5SX4N;^PVHJ
M?8Y8D=22)"["3.<CIC`X]ZN#2@E>VI,D^9NW0POB#KTNL?#L/IVEF#0A+%'%
M<W+8DDP>-B<D+Q]YCSZ5U?BY%?X/7&Y0V-/B(R,X.%YK*N/`'B?6?!T6A:OK
M-C''9Q*EK':1,0[(,*9'8`X`X^4#UYQS8D\*>-KSPDVAWNL:3(DL0@?]RY\M
M%"[=K#&2<'.X>F.]7>&B36C)M+5M;HVOAK&D7P\T81HJAH2QP,9)8Y-<O>PQ
M']H73R8TR;(N?E_BV.,_6NL\&Z-K?A_3(M+U&YT^>SMXMD#6\;K)G)/S$G!'
M/8"L&Y\'^+)?&B>*$O\`1A=PQ&&.)HI?+V88#/.<X;UJ8R7/-WWO^)33Y8JV
MUB'XV1))X5TW<H).IQKGO@I)D?H*[3Q+$G_"(:O%L41_8)EV@<`>6>*P/'OA
M37/%R06=M>:?;V,,J7"^9&YE,@##D@XVX;TS6EJEAXFU+PK+8&YTJ/4+D/%/
M*L4GEB)E8?(-V0_*\G(Z\5-URQ5]AV?-)V.9\'Z?INJ?`^UM-8F:'3V25YY`
M^TJJW#-G/_`169XQUIM4^%MW%H>F/'X?MTAA6\N6*F14D15$2<DC('S-CH>]
M;=CX&UN+X?WOA.ZO[!H#$1:RQ1N&#&0R'>2<8SQP/SJK%X!\3WW@P>&]5UFQ
MBM(8]L*6<;$R$'*>8S8^4''`&??BM%*',Y-];F;C+DY;=+&-XZO7MOA-X/@(
M8VL\=KY^/XE6(';^/7_@->O>7:7MB$V13VDT8PI4,CH1QQT(Q7#6/@+5-0\'
M2:!XIU*">.....R%JG%OL!"ON(!8X(&.F![YJ#1?#7Q#T.TCTNVUW2)-/B^6
M*2:)VEC7T`QCCT)/ITJ9\LHV3U3?XE1YHN[6C2,GQQ8VS?$SPEI"NUA8+'^Y
M%KB+RG+-C9@8!R%[5U&I?#33M8A2'4M9UR[B1MRI->!@#TSRM,\1_#O_`(2#
M0;2WFU>=]6LW:2+4)5&2S')!`QA<XP!]W`Z]Z<'ACQ[?P#3=<\2V@TTC9,]H
MA\^5.ZEBHQD<$\_CW?/>*Y96L'+9N\;W*OC*);?XD>!859BL;,@+')."HY/K
M6I\8/^2=7G_76+_T,58\8^"&URRTM](N4L-0TE@;-VR5`&/E/4_PK@\].G-9
M/B'P;XQ\6:`UIJVL:;'-&5,4%HCK%(P(RTC$$DXS@`8S2A*+<&WM_F$E*TTE
MO_D:7BS_`)([<_\`8.B_DM7_`(<?\D\T7_KA_P"S&F1>%=0N?!%SX?U?5Q<O
M+"(4FC@""(```8S\W(R2<9]JS/"_A[QOH.F1Z:^IZ.UI:H_V?$4CLY.=JN>,
M*">V3CBI;BX.-^MRM5-.W0S/"@`^-_BL``#[.#Q]8Z=\,[];SQAXS:Y8&_:[
M!YZ^6K.H`]AP/RJUIG@_Q7IOB^]\1+?Z,]Q?`)/&8I=@7*YV\Y!^7N31KOP]
MU*/Q4WB7PGJ4-C?RY,\4X/EN3U/`/![@CKS6DI0=XWW2_`A1DK.VS?XG=2:9
M8S7?VQ[.`W?EF,7'ECS`I[!NH%<1H-W8Z1'<^&?!%D^H202EKFYN9<6\#MQ\
MSXRQX^ZH['GK6SH^E^*Y+V&Z\0:S;;(22MIIT95)"01EV;D@9Z8'.#VKFO#/
M@/Q7X<-_I]MK=C#IEW*7,ZQL]R!TRN0%5B,<DMCJ*SBHI-.7^1<F[II$WP2_
MY$27_K]D_P#04JI\*U1M4\:+)]PWV&YQQNDS4_ASP5XQ\)FXM-*UC2SIOGM-
M%%<0L[29`7Y\`%<``_*W4>A-6?"O@WQ)X:U.^G-[I,]OJ-P);N-HI,XR20G.
M!PQZY[5I-Q?.T]R(*2Y;K8YVU_X3/X;V,@T^VM=;\-JQFCE0Y94/.?E.1QR3
MAA7I7A/4=/U;PO8WVEVHM;.96*0*H4(=Q##`X^\#7-Z5X;\8Z)HTF@VE]I$V
MG_.D%S.)/.B1L\;`-K8R<9/Z<5U7AW0X/#>@6>D6SM)';(1O;JQ)+,?Q)-9U
MI1DO._W^I=.+3\C5HHHKG-@HHHH`****`"BBB@#&N_"?A^_U"2_O-'L[FZDQ
MODGB#YP,#@\=`*>OA?P^B[4T+3%4=`+2,?TK6HJN>7<7*NQB3>$/#5P")?#^
MEL3U/V1`?SQFKVF:38:-:FUTZUCMH"Y?RXQ@9/4U=HH<I-6;!12UL%%%%2,*
M***`"BBB@`HHHH`****`"LC6?"^B>(5`U738+D@8#LN'`]`PP1^=:]%--IW0
MFD]&><7/P3\*SN6CDU&W']V*=2/_`!Y2:A7X&^&%8$WFK,/0S1X/Y)7IM%:_
M6*O\QG["GV.2TKX:^$](=9(=)BFE7H]R3+^C<?I75@!0%4``#``[4ZBLY2E+
M63N:1BHZ)!1114C"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
FBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>nr20090715vanoc002.jpg
<TEXT>
begin 644 nr20090715vanoc002.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`!>`7$#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#UK0=!TB3P
M]ILDNE6+LUI$23;H23L'M6A_PCNB#_F#V'_@,G^%.\/<>&]+_P"O2+_T`5I=
M*J4G=ZF<8JRT,S_A'=$_Z`]A_P"`R?X4?\([HG_0'L/_``&3_"M.BIYGW*Y5
MV,S_`(1[1/\`H#V'_@,G^%)_PCVB?]`>P_\``9/\*H>+/$K>'+&&=+?SVDD\
MO&_;C@G-4?"?C*3Q'>3VSV*P^7'OW"3=GG&.E+GUM<YWB**J^Q>YO?\`".Z)
M_P!`>P_\!D_PH_X1W1/^@/8?^`R?X5IT4^9]SHY5V,S_`(1W1/\`H#V'_@,G
M^%'_``CNB?\`0'L/_`9/\*TZ*.9]PY5V,O\`X1[1/^@/I_\`X#)_A2_\(]HG
M_0'L/_`9/\*T&94!)(4#J36!?>,=%L25:\$K`?=A&[]>E:0C4J.T;LRJ5:5)
M7J-(O#P]HO\`T!K#_P`!D_PH/AW1/^@-8?\`@,G^%<C=?$J-21::>['LTKX_
M05G/\1]7<_N[>U4?[K'^M=<,!B9=/Q.">;X*/6_R/0/^$>T3_H#V'_@,G^%'
M_"/:)_T!]/\`_`5/\*R_"'B.77[:X^TI&D\+`$1YP0>G\C73'FN.I"=.;C+<
M[Z%6G6IJI#9GFWQ4TC3;+P3-+:Z=:0R>=&-\<*H>OJ!7A%?0OQ>_Y$&?_KM'
M_P"A5\]=J]?+W>D>;CE:H%%%%>@<04444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'U?X>_P"1:TO_`*](
MO_0!6E6;X>_Y%K2_^O2+_P!`%:5?*RW9])'9'.ZSXST'P],L&IZ@D4S#(C5"
M[X]P!Q69_P`+6\']]2D_\!I/_B:P;_X-IJ%_/>S^()VFF<NY:`$\_C6?=_!F
MTL[=KBY\1LD*]6-I_P#9UV0IX;E]Z3O_`%Y').IB;Z15C0\4^+O!WB:RBMQK
M[6S1R>8&-I*<\$8^[3?"?BCPMH"S";Q)#.'`"`6<B,OKSMR>U<NWP\T,'CQ4
MY_[A[?\`Q=(/A[HG_0T2_P#@N/\`\76GU;#7O=_U\CEY9^U]KRJ_K_P3U-?B
M/X1<?+K<'XHX_I5JV\:^&KN9(K?6[-Y'.%4R8R?QKSRT^#%K>VZ7%OXC:2)_
MNG[)_P#9U93X&VP/SZ[,1[6X']:S=/#?S,ZE4Q/\J/7*#TJ&"(0P1Q;F;8@&
MYNIQZU*WW3]*XSLZ'CWBW6[O4-9N;<SL+6&0QK&IXXXR?7FKWA7PE;:U82W=
MS-(!O,:)$0,>Y_.L!;"_U>_N'M+66;,C$LHX'/K4EKJVK>'Y)8+>22V8G]Y&
MZ=_H:^EE!^Q]E1=I'Q$:M\1[;$1;B[E?5=/.FZM<6+N'\IL;AW'453[X%=9H
M?A*ZUN4ZAJDDD4#MN);[TOOST'O73-X(\/WMKFT)0GCS89=W/ZBE+'TJ/N2=
MWUL7#*JU=.I!671,P?AM+MU6\B_OP!_R/_V5>FBN`\.>';[P_P"*]LH\VVDB
M9$F4<'H?F]#Q7?\`6O'Q\XSK<\'HSZ'*83IX?V=16:;.$^+W_(A3_P#7:/\`
M]"KYZ[5]"_%[_D0I_P#KM'_Z%7SW7=E_\+YF6/\`XH9Q25W'PPFL'\3OIFHV
MT$\-["8T\V,-AUY&,].,C\JO^$O"\.F^,=:EU:)'L-$21Y/,0$-UV<'U7<WY
M5M/$*$G%]#&-!R2:ZGG%%=7H.M7;:Q?SV'ANTU*\NF\R-6MC(+=<GHH[<C\J
M[S4=/FU[X<ZG>Z]H,&GZE:;GB:.'RR0J@Y]<=12GB>22BT.-#F5TSQD\<4@Z
MUZUX=32++X/RZO?Z/;WSPSDX=`"Y\P!<MC.,FKFA7UAX\\):Y#>Z+96KV468
MF@CQMRK$$>A&VI>+:;=M$[%K#7LKZM7/&B`*0'%>D>`O#VE1>'M0\5ZW`+F&
MTR(8'7(8@#DC^+D@#-9.I_$*?4[.YM7T'28X)5*QE8/GB]"#ZCZ5?MY2FU!;
M&?L4HIR>YQW`I*]3LK#3?`_P^M?$-QIT-_JM\R>2+A=R)O!9>/\`=&?6K/AJ
M?3/B79W^G:KIMI:ZC#'OBN+6/:0.GZ'''?-0\5:[MHBEA]E?5GD=%>H_#K2;
M<Z-XKCOK2"6:U78#)&'*L%DSC/3I6=\(+*VO_%=U%=VT4\8LG(26,.`?,3GF
MK>)2Y]-A+#M\OF<!QFCC;[UZ;X'M].U>_P#$OARZMK??/YS6TIC7<AR5.#^1
M_`U3\%Z9!HNC^(O$&KVD4OV%#:113('#3Y]#[[!^)H>(2OIV_$:H-VU_I'GV
M?EQ1GY<5[#X>\,3Z/X(M]:T_18-5UN]VRH)@I2%#R"`2.WISS3/%7AN35?`<
MVM:AHT&F:W:'=(L`4"1,C/W2>Q^O%1]<CSV^17U9\M_F>04O6O78O[$TGX5:
M/K%YH\%Y.DF8QL`\R3+@;CC)'M["O.O$WB%O$FH1W9L+:SV1B/;`N`?<UI2K
MRJ2=EH9U**@M7J8U%7]&U+^R=22]^R6UWY8.(KE-R$XX./;K7I_@GQ1>>-=4
MN-&UC3+&XL3"7;RX<>5Z?S^M.M5E35[:!3I*H[7U/(:7BNR\'^%[+7O'5S8;
MS+IMH\DF0?\`6QA\*,^^16C=_$VYLM7EM=,TS3UT>&1HUMO)'[Q`<9)]3_G-
M*5=\W)!7"-%6O)V/.Z6O1/'.CZ-I5]H_B.RTU7TS44\Q[/<8TSM!'3ID'H/2
MK^IW&GZE\'KC4+32+33RURD>R%.2%<=3U-3]:NDTMQ^PU:;V/+.E)7I/ANRL
M/#/@"3Q?<V<5W?SR;+-9ERB?-C./^`D_A5OPKXH7QOJG]@>);*TG6Z1_)ECB
M"LC!<\'Z`TGB'JXK1%*@M$WJSRNBK^N:8VBZ[>Z:S[OLTIC#>H['\JH&NF,N
M:-T<THV=@HHHJM1'U?X>_P"1:TO_`*](O_0!6E6;X>_Y%K2_^O2+_P!`%:7K
M7RTMV?21V0&N=\:9_P"$??'_`#T7-=%4%U!!<6[QW,:21=2&'%5"7*TQRCS*
MQXW14NG^*$O?%%O;#3=/6RFN1$%\CG83@<^M=E<W4%M=R10:;8JJ,0/W`SQ1
M6SK#TH<S3-JN28FE-0E;57+/@68R:3/$>D<O'XBNK'K6/H=^MY;NOEQQLAY$
M:X&*V`*SA7AB%[6&S,W2E2]R6Z%ICMM0GT&:?3)!NC8>HJD2]CYXU+QYKEW)
MLM)_[-M5/[N"T_=@?4CDUMZ5\3$$$:Z[I,.H7$0_=W*@!OQR/U%9NC_#?7=3
M43SHNG6W7S+G@X_W.OYXK=3P#X4A_=W?B.:27N80JK_(_P`Z]FM5P4%:3/`A
M'$7O^?\`DSF/$_CC5?$KF.1_LUEVMHCPW^\>]8VF:K?Z/="YT^ZDMY1W4_*W
MU'>O1'^%5A>H7T;7Q(1_#(JO^9'3\JY/6O`GB#1<R36?GPC_`):V_P`X_'N/
MQ%=%"OA9QY(-6,ZM+$)\\OO/4O!/CZ#Q*HLKQ5@U)%SL!^64>J_X5W/:OGKX
M;\_$#3/^VG_HMZ^A:\G&THTJO+`]?`U95:5Y'!_%[_D0I_\`KM'_`.A5\]=J
M^A?B]_R(4_\`UVC_`/0J^>NU=^`_A?,X\?\`Q2>RO)M/O[>]@.)K>02(?<'-
M>M?$?Q-82>%(/[-V"?7/+EN&4\[$`X/Z#\#7CU+TKHJT8SFIOH80K.,7%=3U
M;P!)%<>`-3T[2=1M[#7I)<^9*^TE?EQ@]<8R..A-:=O_`,2_X<^(+#4/$=MJ
M6HLDK$"Z\PI\@^0$\GI^M>*]J7`VY[UD\)>3E?K<U6(M%*WD>F6E[:CX$WEJ
M;J$7)GR(?,&\_OD[=:/A=?6MMH7BE+FYBB>2%`@DD"EODDZ9KS,4=35/#)P:
MON[DJO:2=ME8]+^'VN:3=>&M1\):Q=+:K=$F"9S@<@<9Z;@1GWK'U/X<7VEV
MES=2ZOI1MX4+IBXVM+CL!CJ?K7&'!I!1["49MP>Y/ME**4EL>JV=[IWCGX>V
MOAZ6_ALM6L=GE+.^U)"@*KS]#]<U9\,VMA\-+.^U/6-1M9K^:()!:VTFXL.O
MZG'/08KR+@TE2\+HXWT9:Q&SMJCU/X7:M:W;^(;*]NHX+K4AO4L<!B=^<?\`
M??2M/P'X=L?!_B&XDU#Q#ILET]NT:0QR=$W*=Q+=#P.*\:-(*)X6[=G9,<<3
M9*ZV.@T_6CHGCL:JAS'%>N7Q_%&20?T)KL_BUK5H(K31M-:/RI7:]N#$<AW/
MW?ZG\J\LHZ5I+#Q<U/L9QK-1<>YZYIE_;>,_A]9Z+!K":;J]AL55>3R_,"`J
M/JI4_@17*Z_X8UC1-+FFU#Q%9R\@"VCO&=Y,GT:N-ZT4H89PE[KT'*LI+5:G
MI>MWMM)\%-(MEN8C<+,I,0D7>.9.U>:=J*4]*THTO97,ZE3GL:OAS0I/$>L1
MV"7$-N""SRRM@`#KCU/M7K5[X3N].T/^Q?"EWIMK#,/]+N[BX/GS'TX0X'^?
MKX?16=:C*H[WT-*=906QV_A'4X_`OCR6"_GBDAVFVFGA+,@SALCCG!'\ZO7W
MPPN[S6)+K2[^R?1II&D6Y\X8C0G.#ZX_SBO.J*4J$K\\7J*-56Y6M#O_`(DZ
M_I]VFEZ#I,HFL]+A\LR!MP8[0%P>^`.OO4T4L?\`PHJ>/S%\S[;G;NY^^*\Z
MHJOJZ4%!=-1^W;DV^IZ7X;O+'Q1X`D\(W5W%:7\,F^T:5L*_S;L9_P"!$?C5
MCPMX4/@G53K_`(FO+:WCM4<0Q)*&:1BN.!]">*X&PTJWOECWW\=NY0N_F``#
M#@<<\G!)_#%+;:/#<0>8^HPQ.&".C^^.G/N<_2LG1>JB]&6JJT;6J(-<U-M:
MUV]U)DV?:93(%]!V'Y51)IT\?E3O'\_!Q\ZX/Y4RNR,5&-D<TG=W84444R3Z
MO\/?\BUI?_7I%_Z`*TO6LWP]_P`BUI?_`%Z1?^@"M+UKY:6[/I([(3&,5@>,
MK_\`L[PK?3*<,T9C7ZMQ_6M\\U@^*?#Y\2:4+);HVY$@DW[-V<9XQD>M34OR
MNQT89TXUHNI\-]3Q'1#MU[3SZ7,9_P#'Q7I^HY349QC^,FJ.G?"R2SU*WN7U
M4.D,BR;5@QG!SCK797>@0W5PTS2NI;J`*\3%8*K5H\J6MSZ+'YEAJE=2INZM
MYF+H5U]GU&,$_++\I_I7:"N:?1X;2=6*WDI7#`Q1@CK72#@5U990JT:;A5/"
MQE2G4GS0'4AZ&EHKTSD/']:U&_N[^>*\G9PDA3;T`P?2LRO5=2\+:7J<IFDC
M=)F',D38)_I6/+\/[<G]S?RJ/]M0W^%>55PE7FON>15P=5RON<+%+)#()(I'
MC<='0X(KKM$\:R1E8-3_`'D9X$P'(^H[U-_PKP_]!/\`\@__`%Z</`$<:EGO
MWDP,XCB"D_K13HXBF[H5.AB:;O%&U'X;T6?6+;7K:%%NDR1+"<!\@CD#KUK?
MK#\/V$&GP200+>*A(8_:/?TK<KU.:4DN8]2FK+:QP?Q>_P"1"G_Z[1_^A5\]
M=J^A?B]_R(4W_7:/_P!"KYZ[5[>`_A?,\K'_`,4**WO#FBVNHB_O]2>1--TV
M(2S^5]^0DX1!Z9/>M'24\.^)=132!I1TJ:X^6VN8[AY,/V#A^H/MBNF55*_D
M<RIMV\SD>*.*ZS3]-TW3O"]]J&K:6;RY@U`6?E_:'C`^0D]/<4[28-"N].\0
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MXS%8I(4\P$X+G')`QV]:-%@TGQ#XSTVS&F?8[29MLL"SN^3SR">1VJ'52OY#
M5-NWF<O16GHUG#>>*;"PE4M!->1Q,H.,H7`/Z5OQZ;H]AH6K:A<Z8;Q[?5?L
MD:&=TPF">WTIRJQCH"I-G&T5Z!'X6TB/Q#'OMIGLYM&;45M)I"'B?!.PE<<<
M?K52+1='U72=,U6WLIK!9-5CL9K<S%TE!YRA/(]*CZQ$KV#.*HK3UFS@L_%-
M]80J5MX;R2)%)SA`Y`YKK9_#^AZ=J7BYI;!KFWTKR?(@,[I]\@')'UJI5XJP
ME2;//Z7%=;X>M]$\1>+K&T72&M;0QRF2,73OO(C)'/;I45W8:5J'A"XUBSL)
M-.EMKA8=IF,D=QOSTSSD8H]O%2Y6@]F[73.6HHHK<R"BBB@`HHHH`****`"B
MBB@#ZO\`#W_(M:7_`->D7_H`K2K-\/?\BUI?_7I%_P"@"M*OE9;L^DCLA>U<
MZ!<ZOJ-Z@OI[2TM9/)5+?`:1MH9B20>/FP`/0UT7:N?U#3-0ADN[K1KN.*:=
M,R131;U9PN`XY&&P`.XX'%5$4S$NO$YTV^ET235H)+@R1I'>38_=!]^1)C`W
MC8<=,Y7WJ]JD\GANWCU"36IYHPX$D-T4/G`GYMF`"'`YP...GI3TC1=.D\*^
M?+>A7"(TETP">0\>?E*GI@E\ALYW/G[U9NA:;/<:C91ZO=*+=;<&RB\DKYL:
MR,0O+'''E$KU(V#^%L[<L?N,.:?WF]I5P_B6*6]BUF>*/S72.&U*+Y0!P"^5
M)WD<X/'/3O6OHEU/,EU;7++)/9S^2\JC`D^57!QV.'7/OFN>_LZXMO%SIHMY
M"N8)&N$EB\P0[W!`X8=3O8`]/G[&NETS3ETZ!XR[32NYDEE;J['J?Y#'H!6<
M[&L+FE11169J-)P*Y(^(9]7N+HV#^386LXMFN%4&2>8D#;'NX4`D98@^WK76
MD`BN!U739O"'AWS;5VN+&UU!+QHQ'^\6,OEQGOC.>E732>G4RFVM>AWD:>7&
M$RS8'5CDFGURD'B2[>W,MA;Q:Y;XRLME.@<>@=3P#]#^`J?PY+K=[=WU]JMD
M+"*41QV]J9`[J%WY8D<9.X?E0X-*[&JB>B.EHHHJ#0X+XO?\B%/_`-=H_P#T
M*OGNOH3XO?\`(A3_`/7:/_T*OGKM7M8#^%\SQL?_`!3JO"5S:W&FZWX?N;B.
MV?4XHV@EE;:GF1OD`GMGUJUH'AJ]T+7+;5M>46%A8R"8O)(,RL.0D8!^<DXZ
M5QE(.:Z)46[V>Y@JJ5KK8[N#Q%>V_@S5M1L;DVMW<ZR)"$/.'1B?PJOX8U:[
MLO#/BR^BNC%>D6[K*#\Y)EY_F:XRBE]75F@]L[IG7^%+Z6ZN/$]U>3[YYM%N
M-SR'EC\E326C>,/"^E1Z;)&^JZ9&;>2S=PCRQYRCIGK[UQ5%#H>]S1$JNEF=
MIX9T*_T+QIHDFJ11VV^XX1I4WC"]2`<@?6EM;C3]%T'4;F^@DN7U>Z>!(X9Q
M&XBC.2=V#P7P/PKBJ*'1YG>3*56RLD>D">TUC5?!VO6JF$1W,=A<)+*'9/+(
M*$G`W97OCM7->)]`U2RU'4-0FM@MI)=.4D$B'.7..`<USE%$*+@]&$ZJDM4;
M?AW3]>N+AKW0/,^T0$9,4H#<^V<D5V-W?V=AXP\,:AJ:V]OJHW'5?)QL4YPA
M?'`?#9->9T43H<\KLF-7E5D=QI?A34],\46VJ7HA@TNTN1<->M,IC=$;/!SS
MG'`]Z?;:_<6?@W5K[3KCR)I]9#CH3L*,>A_"N%Q24.A?XF4JUOA.Q\%ZI<R^
M)=0U"ZNWDN3IUP?-E?))V\=:S;+6]1U;Q-H[ZE?23)%=P[`YPBC>,X'05@45
M7LHW;)]J[)'7^*?#VIV_B34M5DMA]A:_:02B9#D&3@XSGN*ZMIKPZ]XZ.D3@
M7S^1]G*2`$_,,X)XZ9KR6BH=!M6;_K3_`"+59)Z(]!\,P:Q9?$?3KW7FQ/-'
M+^]DD0YQ$1V/TJG>WL_C'P>)IKAWU31LF1"W^O@)^_CU!Z^U<513]AKS]1>V
MTMT"BBBNDP"BBB@`HHHH`****`"BBB@#ZO\`#_\`R+>E_P#7I%_Z`*TZQ++3
M-8L;&WM4U*P98(UC!-B^2%&/^>M6/L^M_P#01T__`,`7_P#CM?+-*Y](F[;&
MG169]GUO_H(Z?_X`O_\`':/L^M_]!'3_`/P!?_X[18+OL+-HFEW%Y]KFTZTD
MN,@^:\*E\CIS5B[L+6^@\F[MHKB+.=DJ!Q^M5?LVM_\`01L/_`%__CM'V;6_
M^@C8?^`+_P#QVG\Q?(M6=C:6$'DV5K#;Q9SLB0(,_A5FLW[/K?\`T$=/_P#`
M%_\`X[1]GUO_`*".G_\`@"__`,=I#N^QIT5F?9];_P"@CI__`(`O_P#':/L^
MM_\`01T__P``7_\`CM%@N^QITUE!4@C(/:L[[/K?_01T_P#\`7_^.T?9];_Z
M".G_`/@"_P#\=HL%WV+D%M#;1B."*.*,?PQJ%%3UF?9];_Z".G_^`+__`!VC
M[/K?_01T_P#\`7_^.T!=]C3HK,^SZW_T$=/_`/`%_P#X[1]GUO\`Z".G_P#@
M"_\`\=HL%WV.5^+W_(A3C_IM'_Z%7SU7TMXE\*:CXHT5]-N]6M(D9U??%8MG
MCZRFN*_X45_U,?\`Y(__`&RO3P>(I4H<LG^9YV*P]6I/FBCQZBO8?^%%?]3'
M_P"2/_VRC_A17_4Q_P#DC_\`;*Z_KM#^;\&<OU.O_+^*/'J*]A_X45_U,?\`
MY(__`&RC_A17_4Q_^2/_`-LH^NT/YOP8?4Z_\OXH\>HKV'_A17_4Q_\`DC_]
MLH_X45_U,?\`Y(__`&RCZ[0_F_!A]3K_`,OXH\>HKV'_`(45_P!3'_Y(_P#V
MRC_A17_4Q_\`DC_]LH^NT/YOP8?4Z_\`+^*/'J*]A_X45_U,?_DC_P#;*/\`
MA17_`%,?_DC_`/;*/KM#^;\&'U.O_+^*/'J*]A_X45_U,?\`Y(__`&RC_A17
M_4Q_^2/_`-LH^NT/YOP8?4Z_\OXH\>HKV'_A17_4Q_\`DC_]LH_X45_U,?\`
MY(__`&RCZ[0_F_!A]3K_`,OXH\>HKV'_`(45_P!3'_Y(_P#VRC_A17_4Q_\`
MDC_]LH^NT/YOP8?4Z_\`+^*/'J*]A_X45_U,?_DC_P#;*/\`A17_`%,?_DC_
M`/;*/KM#^;\&'U.O_+^*/'J*]A_X45_U,?\`Y(__`&RC_A17_4Q_^2/_`-LH
M^NT/YOP8?4Z_\OXH\>HKV'_A17_4Q_\`DC_]LH_X45_U,?\`Y(__`&RCZ[0_
MF_!A]3K_`,OXH\>HKV'_`(45_P!3'_Y(_P#VRC_A17_4Q_\`DC_]LH^NT/YO
MP8?4Z_\`+^*/'J*]A_X45_U,?_DC_P#;*/\`A17_`%,?_DC_`/;*/KM#^;\&
M'U.O_+^*/'J*]A_X45_U,?\`Y(__`&RC_A17_4Q_^2/_`-LH^NT/YOP8?4Z_
C\OXH\>HKV'_A17_4Q_\`DC_]LHH^NT/YOP8?4Z_\OXH__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>nr20090715vanoc003.jpg
<TEXT>
begin 644 nr20090715vanoc003.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`"6`?0#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#WVBBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBO.?B)\1KO
MP9JMI9VME!<>=#YK&5F&/F('3Z5<(2F^6),YJ"O(]&HKPY?CS?!1NT*W+=R)
MV`_E5A/CXP0;_#8+=R+W`_+RZV^J5>QC]:I=SVFBO&!\?!N&[PT0.^+[/_M.
MIO\`A?5O_P!"_+_X%#_XFE]5K=OR']9I=SV&BO'O^%]6_P#T+\O_`(%#_P")
MIC_'N(#]WX==C_M7@'_LAH^JU>P?6*7<]DHKQC_A?G_4M?\`D_\`_:Z@D^/5
MR7)C\/Q*O8-=$G\]HH^JU>P?6:7<]NK*UWQ%I7ANR^UZK>)`AX13RSGT51R:
M\DB^-^M7=TL-GH%O)(_"1J[NQX]NM>9Z[KNH^(]5EU#4IFEF<X"_PH.RJ.P%
M:T\')OW]$9U,7%+W-3U;5?CNH=DTC1BRC[LMU)C/_`%_^*K(E^-?BR(!WTK3
M(T;[I>"49_'?S7;?#?X<V>AZ9!J>J6JRZM,H<"5<_9P>B@'^+U/X#W[Z^L+7
M4[*6SO;=)[>5=KQN,@C_`#WI2J4(2Y5&XU"M)7<K'AUK\=M;1P;O2M/E3/(A
M+QG'U):O0_"7Q/T3Q3.EG\]EJ#_=MYCD.?\`98<'Z'!]J^>_$FEKHGB74=,1
MBR6UP\:$]2N>,_ABLU'>*19(V9'4AE93@@CN#75+"TIQNE8Y8XFI"5I:GV;1
M7/\`@G6)=?\`!NEZE.<S2Q;9&_O.I*L?Q*DUT%>5).+:9Z:=U=!1112&%%!.
M!DUSFI>//"VDN4N];M`XZI$QE8?4("1347+9";2W.CHKSR7XT>$HR=CWLO\`
MN6^,_F14UK\8?"%S*J-=7,&X@9EMVQ_X[FM/85/Y61[:G_,CO:R=7\2Z+H`7
M^U-2M[5F&51V^8CU"CG'X4>)M8_L#PUJ&J[0S6T)9%/0MT4'VR17FGV"[T.V
M\/7OFVDNOZ_-NNM1OH1*8MRA@%!("@`@<>GI@4Z=-2U83FUHCTK2/$^B:]N&
MEZG;W+J,E$;#@>NT\UKUY%]DG\3IK['["FO:`R26FK:8I03DJ6V-Z_=P?3/Y
M^B^%M9/B#PQIVJLNQ[B$,ZCH''#8]L@T5*:CJ@A/FT9L4445B:!114<\\-M"
MTT\J11(,L[L%51[D]*`)**XK2?B5I&M^,_[`L%:6,Q,R7>["NZ\E57&2,9.[
MVZ8YKM:J4)1TDB8R4M4%%%,=UCC9W.%4$D^@J2A]%<@/BAX,(!_MR+G_`*8R
M?_$TO_"S_!G_`$'(O^_4G_Q-:>RJ?RO[B/:0[G745S^D>-O#NOW_`-ATO4TN
M;G89-BQN/E&,G)`'<5T%0XN+LT4FGL%%%8^N>)]&\-BW.KWJVHG+",LC-NQC
M/W0<=1UH2;=D#:6K-BBN1_X6?X,_Z#D7_?J3_P")H_X6?X,_Z#D7_?J3_P")
MJ_95/Y7]Q/M(=SKJ*XY/BGX+=B!K:9'K!*/YK5^R\=>%M0<);Z[9;CT623RR
M?H&Q2=.:W3!3B]F=%13$=9$#HP96&05.013Z@L****`"BBN)\7?$S1?"I%NK
M"_OMP#6\,@_=C/)9L'!]NOTZU482F[11,I**O([:BF12QSPI-$X>.10RL.A!
MY!I]24%%%%`!1110`4444`%%%%`!1110`5\U?%S5EU/Q]<QQN&CLHUM@1ZC)
M;\F8C\*^E:K1V-G#,TT5I`DK,69UC`8D]23Z\FMJ%54I<S5S*M3=2/+>Q\A0
MV%Y<8\FTGDSC&R,GKTZ"KT7A7Q%,NZ+0=4=<XRMG(1G\J^N**Z7CGTB<_P!2
M7<^0=3T'5M&6-M3TZYM!*2$,\97=CKC/U%9]>N_'B]WZIH]@"/W4+S$?[S`#
M_P!`->15VTIN<%)G'5@H3<4%:>F^'=:UB!I]-TN[NXE;8SPQ%@&QG&1WP1^=
M9E?3/PHT\:?\/-/)!#W)>X?_`($QQ_XZ%J*]7V4;HJA2525F?/DOA;Q#"`9=
M!U2,'IOLY!G]*SYK.ZMQF:VFC'JZ$?SK[(HKE6.?6)U/!+N?-OP>M5N/B':R
M,`?L\,LHSZ[=O_LU>CZG\)[:Z\>VFMVI@BT[S1-=VK9Y<'/RC&,,<9!([^N*
M]#2RM([C[0EK`LV,>8L8#8^M6*QJ8F4I\T=-+&L,/&,>5Z]0HHKF/'?BB+PI
MX8N+OS%%Y*IBM4[M(1UQZ#J?I[UA&+DTD;R:BKL^=/&EXE_XUUFYC;=&UW(%
M;U`.`?R%8=!))))R3U-=U\.O`%SXJU*.\NXFCT>!P978$><1_`OK[GM]:]MR
MC3A=[(\91=2>G4]K^'-A)IOP^T:WE4JYA,I!ZC>Q<?\`H5=335544*H`4#``
M&`*=7B2ES2;[GLQ7*D@KA/&?Q/TGPJSV<`%]J8X,$;86,_[;=OH.?I7.?$SX
MGM8/-H6@3XN@2EU=I_RS[%$/][U/;MST\/9F=BS$LQ.22<DFNS#X7F7-/8Y*
M^*Y?=AN=%XB\<^(/$SL+^_=;<GBVA^2(?@.OXY-4]!\,ZOXENS;Z5923D???
MHB?[S'@5L^`?`UQXRU0AR\.FP$&XG`Y/^PO^T?T'/H#](Z5I%CHFG16&G6R6
M]M&.%4=3ZD]R?4UO6KQH^[!:F-*A*K[TWH>06'P'N'A#:CKD<4I'W(("X'_`
MB1_*G7OP&E6$FQUY'E'1)[<JI_X$&./RKVNBN+ZW5ON=?U:E:UCG=7T*ZU;P
M%-HES,CWLEFL;2C[K2J`<\]BPKA(''C6/POIMQ9QM=Z1<&+5;*=E5E55"[MK
M$%@<=LXKUVL36?".@>()5FU/3(IYE&!*"4?'8;E(/ZU-.KR[ESA?8X*6:3P#
M+XDTBU@+Q:BZ'1;2*178R.N'&S)8`'')&#MZUWWA+1WT#PIINERD&6"$"3'3
M>>6`]LDTS1O!_A_0)FGTS3(H9SUF8M(_X,Q)'YUNT5*BDK((0:U84445B:!7
MEOQJ,=WINC:/#'YFHW=X/(4'MC:>/<LH_.O4J\JT[/B_XU7=\?GL-!C\F/T,
MG(_]"+G_`("*WH:2Y^QE6UCR]SR"RGN_!WC**208N--N]LBJ?O;6PPSZ$9'X
MU]80S1W$$<\3AXY%#HPZ$$9!KY[^,^B_V=XR6_1,1:A$),@<>8ORM^FT_C7I
M_P`)]:_MCP):QN^Z:Q8VKY/.%Y7\-I`_"NC$^_3C41SX?W*DJ9W--95=2K`%
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MSUJ;X]H#;Z$_\0><#Z$)_A6E\"XU'@^_EYW-?LI^@C3_`!-=[F_JJ=_ZN<*B
MOK+5CNG\+^'Y$*/H6FLIZ@VD?^%<KKGP?\,ZK$QLXGTVX/1X"2F?="<8^F*]
M!HKBC5G%W3.N5.,MT?-ER?&'PIUA8%N6%LYW1X)>WG'?@]#Z]",_C7M'@CQS
M8^,].+Q@07\0_?VI;)7_`&E]5/Z=#[W/&'AN#Q5X;N=-E5?-*[[>0_\`+.0?
M=/T['V)KYI\.ZU=^$_$MO?QAEDMY-LT73>N<.A_7\<'M7:E'$P;^TCE;>'FE
M]EGUK145O/'=6T5Q"P:*5`Z,.ZD9!J6O/.TR_$=Y;:?X:U.ZO%#6\=M(70G&
M\;2-N??I^-?*E[H]Y8:;I]_<1[;>_1W@/J%;:<_YZ$5[G\7;^:ZMM*\*V3?Z
M5JMRN\`]$!&,^Q8@_P#`32?%3PS"/AO;K:1\:/Y?EXZ^7@(W]"?I7=AI>S2O
M]IG'B(>TO_=1K_"K6O[8\!V:NVZ:R)M7SZ+]W_QTK^5=M7@?P0ULVGB2ZTB1
MOW=]%O0?]-$R?_02WY"O?*PQ,.2HT;8>?/33"BBBL#8****`"BBB@`HHHH`*
M***`"BBB@`HHH)P,F@#YG^+-_P#;OB'?A3E+94@7\%!/_CQ-<35[7+[^U-?U
M"_\`^?FYDE'T9B15&O=IQY8I'B5)<TVP52S!5!))P!ZU]@Z39#3-'L;`8Q;6
M\</'^RH']*^6_!>G_P!I^-='M"NY7ND9QZJIW-^@-?6-<..EJHG;@HZ.0444
M5P'<%9?B'5UT'P]?ZHR!_LT+2*A.-S?PC/;)P*U*JW^GVFJ64EE?0)/;28WQ
MOT;!!&?Q`IQM=7$[VT/&;KX\WKP;;30H(IL<O+<&1<_0*O\`.O-]:\0:EXGU
M47>KWI=R=H)'R1+GH%'0?3D^YKZ2N/A[X2N8&A?0;-5((W1IL8?\"&#7@_Q$
M\%'P;K:10.\EA=*7MW?J,?>4GN1D?@17I8>=%RM!69Y^(A54;R=T=7X'\)>`
M+F>)[OQ##J=V<%;:0&W3/IM;!?\`/\*]OAABMX4AAC2*)!A410%4>@`Z5\:U
M[+\&_&E[<WS>'-0G>>,QE[1W.63;U3/IC)'IBIQ5"37/>]BL-7C?DM8]IKSK
MXJ>.3X:TL:9I\N-4O%X9>L,?0M]3T'XGM7<:KJ5OH^E76HW;;8+:,R/ZG'8>
MYZ#ZU\G:[K-UX@UJZU2\;,UPY;&>$'0*/8#`_"L<+1YY<SV1MB:O)&RW9GDD
MDDG)/4U>T;2;K7=8M=,LUW3W$@1<]`.Y/L!DGZ51KVSX(>&Q':W7B*>/YY2;
M>V)'11]]A]3@?@:]"M4]G!R//HT_:32/3O#^AV?AS1;?3+),10KRQ'+MW8^Y
M-:E%%>*VV[L]A*RL@HHHI#"BBB@`HHHH`****`,3Q;K8\.^%M0U0D!X8CY6>
M\AX7]2*YWX2:(VE^"X[R8'[3J3FY<MUVGA/T^;_@587Q?N[K6-0T?P?IH\RZ
MN7\]TS@=PF3Z??)^@-2P0?%NVMXK>%=+2*)`B*-G"@8`KJC3_=6NE?N<[G^\
MO:]C0^,VC?VEX+^VQKF73Y1+Q_<;Y6_F#^%</\#]9-IXDN])=OW=[#O0?]-$
MY_\`02WY"NDOK/XL:C87%E<II;P7$;12+E!E6&#_`#KR+3+JZ\*>+K>>5"EQ
MI]UB5`?[K8=?Q&1712A>DZ=TS"K+EJQJ6L?6U%,BECGA2:)P\<BAE8="#R#3
MZ\T[SE_B/_R3S6O^N'_LPKQ?X-_\E"M_^N$O_H->T?$?_DGFM?\`7#_V85XO
M\&_^2A6__7"7_P!!KOH?[O/^NAQUOXT#Z0HHHK@.P****`/'OCU_QYZ'_P!=
M)OY)6I\#/^1)O?\`L(O_`.BXZR?CT1]DT(9Y\R;^25?^!3L?"VHH3\HO<@>Y
M1<_R%=S_`-U7]=3C7^\GJE%%%<)V!7RU\2;-+#XAZS"@`5IA+QZNH<_JU?4M
M?*_Q#OEU'X@:U.I!47'E`C_8`3_V6NW`WYWZ''C/@7J?0'PZN&NOA]HLCDDB
MW\OGT4E1^@KJ*YSP%9M8^`]%@<8;[*LA&,8W?-_[-2^.==_X1SP?J&H*^V?R
M_+@YY\QN%Q],Y_"N:2YJC2ZLZ8OE@F^QQ?AO/B_XP:KKC?/9:0GV:V/4;N5!
M'M_K&_$5Z9J%E%J6G7-C.,PW$31./9A@_P`Z\7\&Z+\1M(T&-]$AL([6\Q<@
MS%"[;@,9SSTQQ[UT/_%W_P#J%_\`CE=%6G>6DEIYF-.=HZQ>IXU8W%SX4\71
M2N,3Z=>8D7UVMAA^(!'XU]9Q2QSPI-$X>.10RL.A!Y!KY<\=Z/KVG:Z;OQ!#
M"EU?#S=T&-C$8!Z=^A/UKW+X6:U_;/@.RWMNFL\VLG_`?N_^.E:TQ:YH1FC+
M"OEG*#.THHHKSSN"BBB@`HHHH`****`"BBB@`HHHH`*Q/%U__9G@_5[S<5:.
MTDV$?WBN%_4BMNO//C-?FS\`O`K8-Y<1PD=R!E__`&05I2CS32(J2Y8-GSI1
M117N'BGHGP6L/M7CK[21\MG;229]VP@_1C^5?15>/?`>PVV6L:BR_P"LDC@5
MO]T%F'_CRU[#7D8N5ZK\CU<+&U-!114-S<0V=M+<W$JQ01*7>1S@*!U)KF.@
MFHKCO!7CJ+QGJ&LQV]MY5K9/&()&/S2JV[DCM]W]:[&JE%Q=I$QDI*Z"O)OC
MN(_[!TIB!YHNF"GVV\_TKUFO!/CAK<=YX@L](A<,+&,O+CL[X./P4`_\"K;"
MINJC+$M*DSRRNW^$<3/\2=-9>D:3,WT\IA_,BN(KV;X&^'9%:]\0S)A&7[-;
MY'WN078?D!GZUZ6(DHTW<\_#Q<JB)OCCXB,5M9^'H'P9?](N`#_"#A!^8)_`
M5XG6]XTUH^(/&&I:@&+1/,4A_P"N:_*OZ`'\:P:="GR4TA5Y\\VQT43S3)%&
MI:1V"JHZDG@"OKC0],A\/^';+3E95CM(`K.3@$@99OQ.37RSX<O[72O$-EJ-
MY$TL-K)YWEKU=EY4>WS`<^GK6SK'B;Q3\0-1-NJW$Z,<QV-HK%%'J0.N/4_I
M66(I2JM*]DC3#U(TTWNV>[:E\2/".ENT<VM0R2`XVVX:7GZJ"/UK('QF\(E]
MOFW@&<;OLYQ]>M>+7O@'Q5I]JUS<Z'=+"@RS*`^T>I"DD"N<J(X2DUH[ERQ5
M5/56/JG2/'WA?6Y5ALM8@,S8`BES$Q/H`P&3],UTM?&->F?#GXFW>CWL.E:S
M<-/I<A")+*V6MST!R?X/;MU'H<JN#LKP9I2Q?,[31]!44`Y&117"=H4444`%
M-=UC1G=@JJ,LQ.`!ZU'<W,-G:375Q((X(4:21ST50,D_D*\P^(7Q,T8^%[FP
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M7>I2^)+!/AYK18X'D`?FP%>,_!O_`)*%;_\`7"7_`-!KT#XA>.O#6I>!]2L;
M+5H;BYG5%CCC#$D[U/IQP#7F/PQUBPT/QI#>ZE<K;VRPR*9&!(!(XZ`UT482
M5"2:,:TDZT7<^GJ*Y?\`X6/X/_Z#UK_X]_A36^)/@]5+'7K;`]`Q_I7#[*?\
MK.SGCW-[4]1M])TNYU"[?9!;QF1S[`=![GH*YOX<:UJOB+PW+JNJ2!C/=2&W
M4(%"1`@!>`,X.X9//%>4_$SXD)XGVZ5I)==+C;=)(PVF=ATXZA1Z'J>>PKUC
M2K_1_`WA+1+#5KV*S<VXP),_,^`7Z?[3?K6TJ+A35UJS&-53F[/1'#?'S_F7
MO^WG_P!I5I?`G_D6M3_Z_/\`V1:Y+XP^)]+\0WNE1Z5>I=1VT<A=D!P"Q7C)
M'^S3OA+XXTWPW]MTW5I3!!<NLL<^TE58#!#8YYXY]JZ73D\-RVU_X)@IQ6);
MOI_P#Z`HK!'C7PN8?-_X2+2]N,X^U)N_+.:YG7?C%X;TR%EL'DU.YQ\JQ*50
M'W8C^0-<,:4Y.R1V.I"*NV=!XW\40^%/#5Q?%U^U.#':H>K2$<<>@ZGZ5\\>
M#/#=QXO\406?S&'=YMW+_=C!^;GU/0>YK7-AXO\`BIK8O6MV$'W5E8%+>!<]
M%)Z_ADFO<O"'A"P\'Z1]CM/WDSG=/<,,-(W]`.P_Q-=?,L/!I/WF<MG7FF_A
M1OHBQQJB*%10`H'``KR?XF3/XF\:Z#X-MV)C,@GN@N>,Y_4(&/\`P*NTU7X@
M>&-%EN8;S5(Q<6^0\"*6?=_=`QUKR?P#XKTN3X@ZMXB\074=M+<1L8"X)"DL
M.`?91@>U94*<E>I;;8UK3B[0ON>^1QI%$D<:A40!54=`!T%/K/TG6M-UVT:Z
MTN[CNH%<QLZ9P&`!(_(C\ZT*YFFG9FZ=]CS;XTZ/]O\`!R:@B9ET^8.3_P!,
MV^5OUV'\*XSX(:Y]C\176CR-^[OHM\8_Z:)D_JI;\A7J/C77O#]II-]I&KZA
M#!+=6;[8V!+$$$`@`>H./I7S1I&ISZ-J]IJ5MCSK:595!Z'!Z'V/3\:]##Q<
MZ+@SAKR4*RFC["HKD-)^)GA;5HK?9J2P7$Q""WF4APQXV],'GN*Z^N"4)1TD
MK'=&2EJF%%%%2,****`"BBB@`HHHH`****`"O%/CQ?YFT?3@?NK)._XD*O\`
M)J]KKYL^,%_]M^(5S&#E;2&.`'\-Q_5S75@XWJW['-BI6I^IPE%%%>L>6?2O
MPCL/L7P\LG(PUR\D[#'JQ4?HHKN:SM!L?[+\/:;8;=IM[:.(CW"@']:T:\*I
M+FFV>W"/+%(*\*^-'B35FU0:`86MM-"K*&S_`,?)]<^@.1CU&3VQ[K61XA\-
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M/^X.OXDCVJH3HT%H[LF<*U9ZJR/*_`_P]U'Q?=),ZO;:4C?O;DC[_JJ>I]^@
M_0^[>));;PG\/;_[#&((K2T,4"C^%C\J_P#CS`^]=''&D,:QQ(J1J-JJHP`!
MV`KSKXV7GV?P,D`;!N;M$(]0`S?S45@ZKKU$GL;JFJ--M;GSS1117JGEE[1M
M)NM=UBUTRS4-/<.$7/0>I/L!DGZ5]2>%_"VG>%-)2QL(ANP#-.1\\K>I/\AV
MKS'X%Z$K2:CKTJ9*8M8"1T)^9S]<;1^)KVJO,QE5N7(MD>EA*24>=[L*^;/B
MWH,&B>-'>UC$<%]$+@(HP%8DA@/Q&?QKZ3KPCX[L/^$ATM<\BU)Q_P`#/^%1
M@VU4L5BTG3N>44445ZQY9]0?#35GUCP%ILTKEIH5-NY/?8<#_P`=VUUU>=?!
M5&7P%EB<-=R%?884?S!KT6O#K)*I)+N>S2=X)OL%%%%9FA#<VT-Y:36MQ&)(
M)D:.1#T92,$?D:Y^/X>^$8L[=`LCG^\F[^==-15*4ELQ.*>Z.7?X=^$78L=`
MM`3_`'00/R!KID58T5$&%48`]!3J*'*4MV"BEL@KF&^'GA%Y"[:#:EB<G@]?
MSKIZ*%*4=F#BGN<VW@'PFRE3X?L,'CB("I]/\'>'M+%Q]ATJ"#[1$89=N?G0
M]5//2MVBG[2>UQ<D5T.83X=^$8V#+H%F3_M*2/R)J7_A`O"?_0OZ?_WY%=%1
M1[2?=AR1['-OX`\)NI4^'['!](L'\Q4?_"N/!_\`T`;7_P`>_P`:ZBBCVD^[
M#DCV.7'PZ\(*P(T&UR.1][_&M/6?#FC^(/)_M:PBN_(W>7YF?EW8SC![X'Y5
MJT4N>3=[ARQVL<U'\/\`PE&NU=`L2,Y^:/=_.F-\.O"#,6.@VF3Z`@?H:ZBB
MG[2?=AR1['+_`/"N/!__`$`;7_Q[_&K5GX,\,Z>0;;0K!6'1F@5F'XG)K>HH
M=2;W;#DBN@T`*`J@``8`':G445!1SUWX'\,W]])>W6C6TUQ*V]W<$[C[\U')
M\/\`PE(,-H%D/]V/;_*NEHJ_:3[LGDCV,_2=%TW0K1K72[2.U@9S(R)G!8@`
MG\@/RK0HHJ6V]64E;8Q=7\)Z#KUTEUJFF0W4Z((U=\Y"@DXX/J3^=54\`>$X
MU"C0+$C_`&H\G\S7244U.25DR>2+Z'-1>`/"D-REQ%H=JDL;AU901M8'((Y]
M:Z6BBDY.6[&DEL%%%%(84444`%%%%`!1110`4444`%?(7B'4#JWB/4K_`#D7
M%S)(N/0L<?IBOJ+Q?J/]D^#]6O=V&CM7V$?WR,+^I%?)E>A@8[R.#&RVB%:O
MA>Q_M+Q7I-D1E9KN-6_W=PS^F:RJ[KX067VOXB6DFW<MM%),?;Y=H_5A7;4E
MRP;.2FN::1]*4445X1[04444`%%%%`!1110`5Y'\>&(TC1UYP9Y#[?='^->N
M5Y7\=+1I/#&GW0Y$-WL;Z,IY_P#'?UK?#?Q48XC^&SP6BBBO9/(/IOX5V`L/
MAYIG&'G#SN?7<QQ_X[MKLZR?#$(MO"FCP@8\NRA7'T05K5X51WFV>W!6BD%?
M./QEO_M?C^6`-D6EO'#^)!?_`-GKZ*FFCMX))IF"1QJ7=CT``R37R+KVJ-K6
MOW^I."#<SO(`>P)X'X#`KJP4;S<NQRXR5H)=S/HHKI_`/AEO%/BNVM&0FTB/
MG73=A&#T_$X'XUZ4I**;9Y\8N321]`?#W3&TCP'I%JZ[9##YKC'.7)?GW^;'
MX5T](`%````%+7A2ES2;9[<59)!1114C.;\61:U'87&HZ7K?V%+6UDD:`VJ2
MB1E!;JW(Z8KD_`]YXL\9:`^J2>*7M'6=H1''80LO`!R<C/?]*[SQ+_R*NL?]
M>4W_`*`:X#X-:G86G@F6.YOK:%_MDAVR2JIQM7G!-=,/X3:6M^QC+^(E<6X\
M;^(/!7B6WTSQ8;:\T^Z.8K^"/RR!G!)7IQQD=L]33O'/BKQ3I'BO2+&%(+32
M[NZ14GC(D>8;EW`Y'R]1P!^)K`^(]_'X^\3:3X?\.D7K6Y?S;B(;HUW%03NZ
M8`7)/3FMCXMM%I]UX/>5]L-O=DLY[*ICR>/85K&,>:-UJ[F3E*TK/16/5Z*X
M*_\`B:FFE+FZ\.:Q%I3L%%[)#M'/0[3R!Z9P3Z5UD^MZ;;Z)_;,MW&NG^4)A
M/V*GH1WYR.*Y'3DK71TJ<7LS1HKA-4^)/]DP07]UX;U2/29V4)=OL!((R#LR
M2..F<9K;\0^,=(\-:3#J-]+(T4XS`L499I>,\=AP>Y%/V4]--Q<\===CH**\
MVN?C#IR)8-9Z5>7GV@)YICQB%F_@ST9QGIQ6G=?%'P]:Z_)I`:XEEBW*[I$2
M/,!P(U'WF8GC@8]Z?L*G87M8=SMJ*X4?$JWM=7@LM:T74='BN3B"YO%"H?\`
M>Y^7J/7&>:;?_$Q+.#[='X<UB?2`<F_$6U"N?O*#SM/8G&:/8S[#]I'N=Y16
M;'KNF2Z"NMB[0:<8O.\]N`%]_?MCKGBN6U+XD?V=81:JWAW4WT:4KMO3L7<#
MC#!"<X.1@G&:F-.4G9(;G%*[9W=%4/[8L%T5=8>X6.P:`7'G/P-A&0?R(XKE
M;_XBR6.FC6#X:U-M%)4?;"44D$\,(R=VT\8)QG(]:(TY2V0.:6YW-%<W=>.-
M$M/#EIKAFDDM[S"VT4:9EE8\;57USD>GO6=/\0?[*OK*'Q!H=YI4%Z=L-Q)(
MDB@^C[3\O4?3\Z%2F^@G.*ZG:T5RE]XZM-/\4VOA^XTS4DN;J41PS&-/*<$X
MW`[LD#Z9J;Q7XRMO",237NFZC/;L!^_MHT:-6).%8E@0>/2CV<KI6W'SQLWV
M.EHKC?%OC671/"<6IV.F7<\]S`)8_P!RQC@!`.Z5AP,9'&>3^=8W@;QO.WA_
M3+6]T7Q#<3.3YNH?9-T!W.3O+[ON@'DX[<"J5&3CS$NK%2Y3=\)^/;/Q;JFH
MV5M97$!L^=\F,.-Q'0=#QTKKJY'PWXUT/Q!XBO=.T:!B8XS-+<^4(UD.X#IU
M/7J:OZMXI@T_4DTJSM+C4M5=/,^R6V!L7^\[,0J#ZFB<'S62L$9+ENW<WZ*Y
M'0_'EMJGB*;P]>Z==:9JT8)\F;:P8`9X93@\<^A'0FB\\<C;=OHVC7NKPV;%
M9[BW*K$".H4DY<CV!I>RG>UA\\;7.BU.2^ATV>33+>*XO57]U%+)L5C[G'^?
M;K7#_#+Q-KGB6_\`$#ZTZ*;>2*..W10JPGY]P'<]!U)Z5U/A;Q-9^+-$34[)
M)(T+F-XY!RK#&1QUZBN*^$O_`"&?&/\`V$!_Z%)5QC:$TUJK?F0W><6GH>H4
M5Q<OCYI8+J]TK0+_`%+2[5F66\B9%4[?O%%)W.!Z@=JZ71]5MM<TBUU.S+_9
M[E-Z;QAA['W!R*SE"45=FBDGHB_1114%!1110`4444`%%%%`'FOQKU/[)X*C
MLE;#WMRJE?5%^8_J%KY[KU+XY:I]I\36.FJV4M+?>P]'<\_HJ_G7EM>QA8\M
M)>9Y6*ES5'Y!7KGP'L]^JZQ?8_U4"0@_[[$_^R5Y'7O7P+M/+\+ZC=D<S7FS
M\%0?U8T8IVI,,*KU4>J4445XYZH4444`%%%%`!1110`5@>,]"_X23PEJ&F*`
M9I(]T.?^>B_,OTR1CZ$UOT4XMQ=T)I-69\921O%(T<BE74E65A@@CJ#25[I\
M3/AA)JL\FN:#&#>-\US:C`\W_:7_`&O4=_KU\.G@FMIW@GB>*5#ATD4JRGT(
M/2O:I58U(W1X]6E*F[,^K?!E_'J?@S1[J-MP-I&C'/\`$HVL/S!K>KYD\$_$
M?4O!J/:K"EY8.V\P.VTJW<JV#C/T-=3JWQUO)[5H]*TB.UE88\Z:7S-OT7`&
M?KGZ5P3PE3G?+L=\,53Y=7J=%\8?%\>F:(V@VLH-[>KB8`\Q0]\^[=/IGVKP
M&IKR\N=0O);N[F>:XF8O)(YR6-;_`(9\":]XJE4V5HT=KGYKJ8%8Q]#_`!'V
M&:[J<(T86;.*I.5:>B,*PL+K5+Z&RLH'GN9FVI&@Y)_SWKZ=\">#;?P=H8M@
M5DO9L/=3#^)NP'^R.WXGO2>#?`FE^#;0BW!GOI%Q-=N,,WL!_"OM^9-=57!B
M<1[3W8[';A\/[/WI;A1117(=04444`9?B7_D5=8_Z\IO_0#7F_P=T/1=6\'3
MS7^D6-U,EZ\?F7%LDC8V(<9()QS7>>*+#7M4L9+'2;C3X(+B"2*=KF-V<;AC
MY-IP.">H/:N=\$^$/$W@Z#[#'?Z5/827/G3!HI/,Y`#;3D#.%'4&NB#2I-7U
M,9)NHG;0[BRTZQTV(QV-E;VL9ZK!$J`_@!7G'Q;`;6/!ZL`0;\@@]_FCKU&O
M/O%W@_Q)XGUBRN5OM+AM]/N#-:H8I"QY4_.<\_=[8J:$DJG-)CJIN%DC<^($
M:2>`-;5U#`6K-@^HY!_,"N:T'3M)U?X+Z;'KT[1:?$AEDD5]N`LC8Y_3_P"O
M70^(-*\1ZUX9&F)<:5%/<Q-'>N8Y"O/3R^<CO][-8*^`]<E^'5SX4N;^PVHJ
M?8Y8D=22)"["3.<CIC`X]ZN#2@E>VI,D^9NW0POB#KTNL?#L/IVEF#0A+%'%
M<W+8DDP>-B<D+Q]YCSZ5U?BY%?X/7&Y0V-/B(R,X.%YK*N/`'B?6?!T6A:OK
M-C''9Q*EK':1,0[(,*9'8`X`X^4#UYQS8D\*>-KSPDVAWNL:3(DL0@?]RY\M
M%"[=K#&2<'.X>F.]7>&B36C)M+5M;HVOAK&D7P\T81HJAH2QP,9)8Y-<O>PQ
M']H73R8TR;(N?E_BV.,_6NL\&Z-K?A_3(M+U&YT^>SMXMD#6\;K)G)/S$G!'
M/8"L&Y\'^+)?&B>*$O\`1A=PQ&&.)HI?+V88#/.<X;UJ8R7/-WWO^)33Y8JV
MUB'XV1))X5TW<H).IQKGO@I)D?H*[3Q+$G_"(:O%L41_8)EV@<`>6>*P/'OA
M37/%R06=M>:?;V,,J7"^9&YE,@##D@XVX;TS6EJEAXFU+PK+8&YTJ/4+D/%/
M*L4GEB)E8?(-V0_*\G(Z\5-URQ5]AV?-)V.9\'Z?INJ?`^UM-8F:'3V25YY`
M^TJJW#-G/_`169XQUIM4^%MW%H>F/'X?MTAA6\N6*F14D15$2<DC('S-CH>]
M;=CX&UN+X?WOA.ZO[!H#$1:RQ1N&#&0R'>2<8SQP/SJK%X!\3WW@P>&]5UFQ
MBM(8]L*6<;$R$'*>8S8^4''`&??BM%*',Y-];F;C+DY;=+&-XZO7MOA-X/@(
M8VL\=KY^/XE6(';^/7_@->O>7:7MB$V13VDT8PI4,CH1QQT(Q7#6/@+5-0\'
M2:!XIU*">.....R%JG%OL!"ON(!8X(&.F![YJ#1?#7Q#T.TCTNVUW2)-/B^6
M*2:)VEC7T`QCCT)/ITJ9\LHV3U3?XE1YHN[6C2,GQQ8VS?$SPEI"NUA8+'^Y
M%KB+RG+-C9@8!R%[5U&I?#33M8A2'4M9UR[B1MRI->!@#TSRM,\1_#O_`(2#
M0;2WFU>=]6LW:2+4)5&2S')!`QA<XP!]W`Z]Z<'ACQ[?P#3=<\2V@TTC9,]H
MA\^5.ZEBHQD<$\_CW?/>*Y96L'+9N\;W*OC*);?XD>!859BL;,@+')."HY/K
M6I\8/^2=7G_76+_T,58\8^"&URRTM](N4L-0TE@;-VR5`&/E/4_PK@\].G-9
M/B'P;XQ\6:`UIJVL:;'-&5,4%HCK%(P(RTC$$DXS@`8S2A*+<&WM_F$E*TTE
MO_D:7BS_`)([<_\`8.B_DM7_`(<?\D\T7_KA_P"S&F1>%=0N?!%SX?U?5Q<O
M+"(4FC@""(```8S\W(R2<9]JS/"_A[QOH.F1Z:^IZ.UI:H_V?$4CLY.=JN>,
M*">V3CBI;BX.-^MRM5-.W0S/"@`^-_BL``#[.#Q]8Z=\,[];SQAXS:Y8&_:[
M!YZ^6K.H`]AP/RJUIG@_Q7IOB^]\1+?Z,]Q?`)/&8I=@7*YV\Y!^7N31KOP]
MU*/Q4WB7PGJ4-C?RY,\4X/EN3U/`/![@CKS6DI0=XWW2_`A1DK.VS?XG=2:9
M8S7?VQ[.`W?EF,7'ECS`I[!NH%<1H-W8Z1'<^&?!%D^H202EKFYN9<6\#MQ\
MSXRQX^ZH['GK6SH^E^*Y+V&Z\0:S;;(22MIIT95)"01EV;D@9Z8'.#VKFO#/
M@/Q7X<-_I]MK=C#IEW*7,ZQL]R!TRN0%5B,<DMCJ*SBHI-.7^1<F[II$WP2_
MY$27_K]D_P#04JI\*U1M4\:+)]PWV&YQQNDS4_ASP5XQ\)FXM-*UC2SIOGM-
M%%<0L[29`7Y\`%<``_*W4>A-6?"O@WQ)X:U.^G-[I,]OJ-P);N-HI,XR20G.
M!PQZY[5I-Q?.T]R(*2Y;K8YVU_X3/X;V,@T^VM=;\-JQFCE0Y94/.?E.1QR3
MAA7I7A/4=/U;PO8WVEVHM;.96*0*H4(=Q##`X^\#7-Z5X;\8Z)HTF@VE]I$V
MG_.D%S.)/.B1L\;`-K8R<9/Z<5U7AW0X/#>@6>D6SM)';(1O;JQ)+,?Q)-9U
MI1DO._W^I=.+3\C5HHHKG-@HHHH`****`"BBB@#&N_"?A^_U"2_O-'L[FZDQ
MODGB#YP,#@\=`*>OA?P^B[4T+3%4=`+2,?TK6HJN>7<7*NQB3>$/#5P")?#^
MEL3U/V1`?SQFKVF:38:-:FUTZUCMH"Y?RXQ@9/4U=HH<I-6;!12UL%%%%2,*
M***`"BBB@`HHHH`****`"LC6?"^B>(5`U738+D@8#LN'`]`PP1^=:]%--IW0
MFD]&><7/P3\*SN6CDU&W']V*=2/_`!Y2:A7X&^&%8$WFK,/0S1X/Y)7IM%:_
M6*O\QG["GV.2TKX:^$](=9(=)BFE7H]R3+^C<?I75@!0%4``#``[4ZBLY2E+
M63N:1BHZ)!1114C"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
FBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3
<SEQUENCE>7
<FILENAME>nr20090717ppincrease.htm
<DESCRIPTION>NEWS RELEASE DATED JULY 17, 2009 - PRIVATE PLACEMENT INCREASE
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>ALDA News Release</TITLE>
<META NAME="keywords" CONTENT="DJL\11861-19\NewsRelease(AmendedOffering-GPWComments).doc">
<META NAME="author" CONTENT="Dan Byrne">
<META NAME="date" CONTENT="07/20/2009">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:960px"><P style="line-height:20pt; margin-top:0px; margin-bottom:28px; font-size:20pt" align=center><B>ALDA PHARMACEUTICALS CORP.</B></P>
<P style="line-height:12.6pt; margin:0px; font-size:12pt" align=center><B>635 Columbia Street<BR>
New Westminster, British Columbia V3M 1A7</B></P>
<P style="line-height:normal; margin:0px; padding-left:-6px; font-size:12pt" align=center><B>Tel: (604) 521-8300 Fax: (604) 521-8322<BR>
</B><FONT style="font-size:16pt"><B>NEWS RELEASE</B></FONT></P>
<P style="line-height:20pt; margin:0px; padding-bottom:4px; font-size:18pt; border-bottom:1px solid #000000" align=center><B>ALDA Pharmaceuticals Increases Private Placement</B></P>
<P style="line-height:13pt; margin-top:7.333px; margin-bottom:0px; font-size:11pt" align=justify>July 17, 2009 Vancouver, BC - ALDA Pharmaceuticals Corp. (APH:TSX-V) (the &#147;Company&#148;) announces that the private placement disclosed in a new release dated July 3, 2009 of up to 3 million common share and warrant units of the Company at a price of $0.20 per unit has been terminated and that the Company will instead proceed with an offering of up to 6 million Units at a price of $0.25 for proceeds up to $1,500,000. &nbsp;Each Unit consists of one common share of ALDA and one non-transferable share purchase warrant entitling the holder to acquire one additional common share of ALDA at a price of $0.40 per common share for a period of twelve (12) &nbsp;months from the date of the issuance of the purchase warrant with a forced exercise provision attached to each warrant commencing on the day following the expiry of any applicable hold period on the underlying Common Share, stating that if, for ten consecutiv
e trading days, the closing price of the listed shares of the Company exceeds $0.80 then the exercise period of the warrants will be reduced to a period of 10 days following such trading days.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>The offering is being made on a private placement basis pursuant to registration and prospectus exemptions of applicable securities laws and is subject to acceptance by the TSX Venture Exchange. &nbsp;All securities issued will be subject to a four-month restricted period and will bear a restrictive legend accordingly. &nbsp;Net proceeds from the offering will be used for working capital.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify><B>About ALDA Pharmaceuticals Corp.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>ALDA is focused on the development of infection-control therapeutics derived from its patented T<SUP>3</SUP>6<SUP>&#174;</SUP> technology. The company trades on the TSX Venture Exchange under the symbol APH and on the OTCBB under the symbol APCSF.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>Terrance G. Owen, Ph.D., MBA</P>
<P style="line-height:13pt; margin:0px; font-size:11pt">President &amp; CEO <BR>
ALDA Pharmaceuticals Corp.</P>
<P style="line-height:13pt; margin:0px; font-size:11pt; color:#0000FF" align=justify><I><U>www.aldacor<A NAME="_Hlt115846424"></A>p.com</U></I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt"><U>Distribution &amp; Sales Contact<BR>
</U>Diane Mann</P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>(604) &nbsp;657-0369</P>
<P style="line-height:13pt; margin:0px; font-size:11pt; color:#0000FF" align=justify><I><U>diane_mann@aldacorp.com<BR>
</U></I></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify><U>Retail Sales</U></P>
<P style="line-height:13pt; margin-top:0px; margin-bottom:-17.333px; font-size:11pt" align=justify>Eastern Esthetics (ON, QU, NB, NS, PE, NL) </P>
<P style="line-height:13pt; margin:0px; text-indent:336px; font-size:11pt" align=justify>902-450-2161</P>
<P style="line-height:13pt; margin-top:0px; margin-bottom:-17.333px; font-size:11pt" align=justify>LCN Canada &#150; West (MB, SK, AB, BC, NW, YK) </P>
<P style="line-height:13pt; margin:0px; text-indent:336px; font-size:11pt" align=justify>780-462-2580</P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify><U>Investor Relations Contact</U></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>Scott Young</P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>604-288-7222</P>
<P style="line-height:13pt; margin:0px; font-size:11pt; color:#0000FF" align=justify><I><U>scott_young@aldacorp.com </U></I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify><I>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify><I>The Units, Common Share, Warrantss and the common shares issuable upon exercise of the Warrants have not been registered under the United States Securities Act of 1933 (the &#147;Act&#148;) and may not be offered or sold absent registration under the Act or an applicable exemption from the registration requirements thereof. &nbsp;This news release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction or an exemption therefrom.</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify><I>Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves ALDA&#146;s expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. ALDA generally uses words such as &#147;outlook,&#148; &#147;will,&#148; &#147;could,&#148; &#147;would,&#148; &#147;might,&#148; &#147;remains,&#148; &#147;to be,&#148; &#147;plans,&#148; &#147;believes,&#148; &#147;may,&#148; &#147;expects,&#148; &#147;intends,&#148; &#147;anticipates,&#148; &#147;estimate,&#148; &#147;future,&#148; &#147;plan,&#148; &#147;positioned,&#148; &#147;potential,&#148; &#147;project,&#148; &#147;remain,&#148; &#147;scheduled,&#148; &#147;set to,&#148; &#147;subject to,&#148; &#147;upcoming,&#148; and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon informa
tion available to ALDA as of the date of this release, and ALDA assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of ALDA and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.</I> </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR>
<BR></P>
</DIV></BODY>
<!-- EDGAR Validation Code: 358716C9 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>8
<FILENAME>nr20090714uspatentcont.htm
<DESCRIPTION>NEWS RELEASE DATED JULY 14, 2009 - US PATENT CONTINUATION
<TEXT>
<HTML>
<head><title>ALDA News Release</title> </head> <body style="LINE-HEIGHT:12pt; FONT-FAMILY:Times New Roman; COLOR:#000000; FONT-SIZE:10pt">
<div style=WIDTH:960px> <p style="LINE-HEIGHT:20pt; MARGIN-TOP:0px; MARGIN-BOTTOM:13px; FONT-SIZE:20pt" align=center>
<b>ALDA PHARMACEUTICALS CORP.</b></p> <p style="LINE-HEIGHT:12.6pt; MARGIN:0px; FONT-SIZE:12pt" align=center>
<b>635 Columbia Street<br>New Westminster, British Columbia V3M 1A7</b></p> <p style="LINE-HEIGHT:20pt; MARGIN:0px; FONT-SIZE:12pt" align=center>
<b>Tel: (604) 521-8300 Fax: (604) 521-8322</b></p> <p style="LINE-HEIGHT:29pt; MARGIN:0px; FONT-SIZE:18pt" align=center>
<b>NEWS RELEASE</b><font style=FONT-SIZE:10pt></p></font> <p style="BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:4px; LINE-HEIGHT:20pt; MARGIN:0px; FONT-SIZE:18pt" align=center>
<b><font style=FONT-SIZE:10pt><br></font>ALDA receives US Patent No. 7,560,422 for T<sup>3</sup>6<sup>&#174;</sup></b></p>
<p style=MARGIN:0px align=justify><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>
<b>JULY 14, 2009 - VANCOUVER, BC - ALDA PHARMACEUTICALS CORP. (APH:TSX-V, "ALDA") </b>is pleased to announce that the United States Patent and Trademark Office ("USPTO") has issued U.S. Patent Number 7,560,422 today. The patent is a continuation of US Patent Number 7,338,927 that was issued on March 4, 2008 and provides further protection for ALDA's T
<sup>3</sup>6<sup>&#174;</sup> formulation until August 20, 2022. The new patent includes claims to additional aspects of the T
<sup>3</sup>6<sup>&#174;</sup> formulation, including the use of T<sup>3</sup>6<sup>&#174;</sup> as a component of a personal lubricant, in a method of preventing or reducing the transmission of a sexually transmitted diseases including
<i>Herpes</i>, <i>Chlamydia</i> and HIV and for use in sanitizers and cleansers in creams, ointments and wipes.</p>
<p style=MARGIN:0px><br></p> <p style="LINE-HEIGHT:14pt; MARGIN-TOP:0px; MARGIN-BOTTOM:8px; FONT-SIZE:12pt" align=justify>Dr. Terrance Owen, President & CEO, states, "Issuance of this new US patent is an important step for ALDA because it provides protection for T
<sup>3</sup>6<sup>&#174;</sup> for certain therapeutic uses. This ties in well with our strategy of registering T
<sup>3</sup>6<sup>&#174;</sup> for therapeutic applications and provides a complement to the new PCT application which is in progress and covers more broad ranging therapeutic applications.&#148;</p>
<p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt"><b>About ALDA Pharmaceuticals Corp.</b></p> <p style=MARGIN:0px>
<br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt" align=justify>ALDA is focused on the development of infection-control therapeutics derived from its patented T
<sup>3</sup>6<sup>&#174;</sup> technology. The company trades on the TSX Venture Exchange under the symbol APH and on the OTCBB under the symbol APCSF.</p>
<p style=MARGIN:0px><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt">Terrance G. Owen, Ph.D., MBA</p>
<p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; FONT-SIZE:12pt">President & CEO <br>ALDA Pharmaceuticals Corp.</p>
<p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; COLOR:#0000ff; FONT-SIZE:12pt"><i><u>www.aldacor
<a name=_Hlt115846424 />p.com</u></i></p> <p style=MARGIN:0px><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; FONT-SIZE:12pt">
<u>Distribution & Sales Contact<br></u>Diane Mann</p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; FONT-SIZE:12pt">(604) &nbsp;657-0369</p>
<p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; COLOR:#0000ff; FONT-SIZE:12pt"><i><u>diane_mann@aldacorp.com
<br></u></i></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; FONT-SIZE:12pt"><u>Retail Sales</u></p>
<p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt">Eastern Esthetics (ON, QU, NB, NS, PE, NL) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;902-450-2161</p>
<p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt">LCN Canada &#150; West (MB, SK, AB, BC, NW, YK) &nbsp;&nbsp;780-462-2580</p>
<p style=MARGIN:0px>&nbsp;</p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; FONT-SIZE:12pt">
<u>Investor Relations Contact</u></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; PADDING-RIGHT:268px; FONT-SIZE:12pt">Scott Young</p>
<p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt">604-288-7222</p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; COLOR:#0000ff; FONT-SIZE:12pt">
<i><u>syoung@freeformcom.com</u></i><font style=COLOR:#000000> </font></p> <p style="LINE-HEIGHT:12.6pt; MARGIN:0px">
<br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt"><i>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.</i></p>
<p style=MARGIN:0px><br></p> <p style="LINE-HEIGHT:14pt; MARGIN:0px; FONT-SIZE:12pt"><i>Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves ALDA&#146;s expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. ALDA generally uses words such as &#147;outlook,&#148; &#147;will,&#148; &#147;could,&#148; &#147;would,&#148; &#147;might,&#148; &#147;remains,&#148; &#147;to be,&#148; &#147;plans,&#148; &#147;believes,&#148; &#147;may,&#148; &#147;expects,&#148; &#147;intends,&#148; &#147;anticipates,&#148; &#147;estimate,&#148; &#147;future,&#148; &#147;plan,&#148; &#147;positioned,&#148; &#147;potential,&#148; &#147;project,&#148; &#147;remain,&#148; &#147;scheduled,&#148; &#147;set to,&#148; &#147;subject to,&#148; &#147;upcoming,&#148; and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are bas
ed upon information available to ALDA as of the date of this release, and ALDA assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of ALDA and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.</i> </p>
<p style=MARGIN:0px align=justify><br></p> <p style=MARGIN:0px align=justify><br><br></p></div></body>
<!-- EDGAR Validation Code: 502103CC -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
